Structured Review

NeuroMab kv1 3
Cartoon representing the structural <t>Kv1.3-associated</t> proteins in the T-lymphocyte immunological synapse. The Kv1.3 channelosome merges a number of proteins modulating channel function at the IS during immunological synapses. PSD95 (also named synapse-associated protein 90; SAP90), which is encoded by the hDLG4 (discs large homolog 4) gene, stabilizes Kv1.3 at the IS. SAP97 (synapse-associated protein 97; hDlg1 ) plays similar roles. Therefore, SAP peptides bind to the PDZ domain in the C-terminus of Kv1.3, coupling p56lck to CD4. Kvβ2 links the N-terminus of the Kv1.3 channel to the ZIP1/2 protein, which may interact with several partners, such as p56lck and PKC. CD3 and Kv1.3 are in molecular proximity, and the channel interacts with β1-integrins. Our data indicate that ~ 10% of Kvβ2 targets to lipid rafts either associated or not with Kv1.3 and situate palmitoylated Kvβ2 (red sparkline) at the IS, independent of the Kv1.3 interaction, and stabilized by PSD95. Kvβ2 may link cellular metabolic activity and redox state with calcium signaling in lymphocytes. Kvβ2 also serves as a bridge with ZIP-1/2, which also links the complex to p56lck. Other proteins within IS are the T-cell receptor (TCR), CD3 and CD4 accessory proteins. Kvβ2 in activated T cells concentrates on the IS during synapse formation. Under proliferation, Kvβ2 targets lipid rafts, which are concentrated at the IS. In contrast, PKC activation triggers a lipid raft displacement of Kvβ2, which PSD95 counteracts
Kv1 3, supplied by NeuroMab, used in various techniques. Bioz Stars score: 88/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1 3/product/NeuroMab
Average 88 stars, based on 20 article reviews
Price from $9.99 to $1999.99
kv1 3 - by Bioz Stars, 2022-11
88/100 stars

Images

1) Product Images from "S-acylation-dependent membrane microdomain localization of the regulatory Kvβ2.1 subunit"

Article Title: S-acylation-dependent membrane microdomain localization of the regulatory Kvβ2.1 subunit

Journal: Cellular and Molecular Life Sciences

doi: 10.1007/s00018-022-04269-3

Cartoon representing the structural Kv1.3-associated proteins in the T-lymphocyte immunological synapse. The Kv1.3 channelosome merges a number of proteins modulating channel function at the IS during immunological synapses. PSD95 (also named synapse-associated protein 90; SAP90), which is encoded by the hDLG4 (discs large homolog 4) gene, stabilizes Kv1.3 at the IS. SAP97 (synapse-associated protein 97; hDlg1 ) plays similar roles. Therefore, SAP peptides bind to the PDZ domain in the C-terminus of Kv1.3, coupling p56lck to CD4. Kvβ2 links the N-terminus of the Kv1.3 channel to the ZIP1/2 protein, which may interact with several partners, such as p56lck and PKC. CD3 and Kv1.3 are in molecular proximity, and the channel interacts with β1-integrins. Our data indicate that ~ 10% of Kvβ2 targets to lipid rafts either associated or not with Kv1.3 and situate palmitoylated Kvβ2 (red sparkline) at the IS, independent of the Kv1.3 interaction, and stabilized by PSD95. Kvβ2 may link cellular metabolic activity and redox state with calcium signaling in lymphocytes. Kvβ2 also serves as a bridge with ZIP-1/2, which also links the complex to p56lck. Other proteins within IS are the T-cell receptor (TCR), CD3 and CD4 accessory proteins. Kvβ2 in activated T cells concentrates on the IS during synapse formation. Under proliferation, Kvβ2 targets lipid rafts, which are concentrated at the IS. In contrast, PKC activation triggers a lipid raft displacement of Kvβ2, which PSD95 counteracts
Figure Legend Snippet: Cartoon representing the structural Kv1.3-associated proteins in the T-lymphocyte immunological synapse. The Kv1.3 channelosome merges a number of proteins modulating channel function at the IS during immunological synapses. PSD95 (also named synapse-associated protein 90; SAP90), which is encoded by the hDLG4 (discs large homolog 4) gene, stabilizes Kv1.3 at the IS. SAP97 (synapse-associated protein 97; hDlg1 ) plays similar roles. Therefore, SAP peptides bind to the PDZ domain in the C-terminus of Kv1.3, coupling p56lck to CD4. Kvβ2 links the N-terminus of the Kv1.3 channel to the ZIP1/2 protein, which may interact with several partners, such as p56lck and PKC. CD3 and Kv1.3 are in molecular proximity, and the channel interacts with β1-integrins. Our data indicate that ~ 10% of Kvβ2 targets to lipid rafts either associated or not with Kv1.3 and situate palmitoylated Kvβ2 (red sparkline) at the IS, independent of the Kv1.3 interaction, and stabilized by PSD95. Kvβ2 may link cellular metabolic activity and redox state with calcium signaling in lymphocytes. Kvβ2 also serves as a bridge with ZIP-1/2, which also links the complex to p56lck. Other proteins within IS are the T-cell receptor (TCR), CD3 and CD4 accessory proteins. Kvβ2 in activated T cells concentrates on the IS during synapse formation. Under proliferation, Kvβ2 targets lipid rafts, which are concentrated at the IS. In contrast, PKC activation triggers a lipid raft displacement of Kvβ2, which PSD95 counteracts

Techniques Used: Activity Assay, Activation Assay

Human T lymphocytes express palmitoylated Kvβ2.1, which targets lipid raft microdomains and concentrates in the IS during the immunological response. ( A ) Human CD4 + lymphocytes express Kvβ2 and Kv1.3. T lymphocytes from 4 different donors (D1-4) were obtained and analyzed. ( B ) Kvβ2 undergoes palmitoylation in human CD4 + T-cells. SN, supernatant in the absence (−) or the presence (+) of HA. SM, starting material in the absence (−) or the presence (+) of HA. PD, pulldown of palmitoylated proteins in the absence (−) or presence (+) of HA. C Human Jurkat T lymphocytes express Kvβ2 and Kv1.3. D Kvβ2 undergoes palmitoylation in human Jurkat T cells. SM, starting material in the presence of HA. PD, pulldown of palmitoylated proteins in the presence of HA. E Proximity ligation assay (PLA) in Jurkat lymphocytes. Palmitic Alk-C16 Kvβ2 palmitoylation. Total Kvβ2 in green; Alk-C16 Kvβ2 palmitoylation in red; merged panel highlights Alk-C16 palmitoylation at the cell surface. F Kvβ2 targets lipid rafts in Jukat cells. Lipid raft fractions were sequentially extracted from the top (1, lowest density and highest buoyancy) to the bottom (12, highest density and lowest buoyancy) of the tube. Because T cells lack the expression of caveolin, flotillin identified lipid rafts. G Cell conjugates between human Jurkat T cells and human Raji B lymphocytes. (Ga-Ge) SEE-activated B lymphocytes were cocultured in the presence of Jurkat cells. Merged panel showing triple colocalization in white (white arrow) localizes Kvβ2 in the IS. Panel Ge shows the accumulation ratio of Kvβ2 at the IS vs. the entire Kvβ2 cell intensity. Values represent mean ± SE. *** p
Figure Legend Snippet: Human T lymphocytes express palmitoylated Kvβ2.1, which targets lipid raft microdomains and concentrates in the IS during the immunological response. ( A ) Human CD4 + lymphocytes express Kvβ2 and Kv1.3. T lymphocytes from 4 different donors (D1-4) were obtained and analyzed. ( B ) Kvβ2 undergoes palmitoylation in human CD4 + T-cells. SN, supernatant in the absence (−) or the presence (+) of HA. SM, starting material in the absence (−) or the presence (+) of HA. PD, pulldown of palmitoylated proteins in the absence (−) or presence (+) of HA. C Human Jurkat T lymphocytes express Kvβ2 and Kv1.3. D Kvβ2 undergoes palmitoylation in human Jurkat T cells. SM, starting material in the presence of HA. PD, pulldown of palmitoylated proteins in the presence of HA. E Proximity ligation assay (PLA) in Jurkat lymphocytes. Palmitic Alk-C16 Kvβ2 palmitoylation. Total Kvβ2 in green; Alk-C16 Kvβ2 palmitoylation in red; merged panel highlights Alk-C16 palmitoylation at the cell surface. F Kvβ2 targets lipid rafts in Jukat cells. Lipid raft fractions were sequentially extracted from the top (1, lowest density and highest buoyancy) to the bottom (12, highest density and lowest buoyancy) of the tube. Because T cells lack the expression of caveolin, flotillin identified lipid rafts. G Cell conjugates between human Jurkat T cells and human Raji B lymphocytes. (Ga-Ge) SEE-activated B lymphocytes were cocultured in the presence of Jurkat cells. Merged panel showing triple colocalization in white (white arrow) localizes Kvβ2 in the IS. Panel Ge shows the accumulation ratio of Kvβ2 at the IS vs. the entire Kvβ2 cell intensity. Values represent mean ± SE. *** p

Techniques Used: Proximity Ligation Assay, Expressing

2) Product Images from "KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology"

Article Title: KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology

Journal: Scientific Reports

doi: 10.1038/s41598-021-94015-9

KCNE4 impaired Kv1.3 accumulation in the IS but did not disrupt IS formation. Human Jurkat T lymphocytes and human Raji B lymphocytes were used to generate cell conjugates. ( A – C ) Activated B-cells (10 µg/mL SEE toxin) were cocultured in the absence ( Ba – Bd ) or presence ( Ca – Cd ) of Jurkat cells, and confocal images were obtained. ( Aa – Ad ) Jurkat T-cells in the absence of B cells. Endogenous Kv1.3 (green), CD3 (marker of T-cells, red), and CD19 (marker of B-cells, blue) were detected. ( Ad , Bd , Cd ) merge panels. Note that triple colocalization (white) in Cd localizes Kv1.3 in the IS, as identified by CD3 staining ( Cb ). Bars are 20 µm. ( D ) Accumulation ratio of mGFP-Kv1.3 at the IS vs. KCNE4-mCherry total intensity (n = 40). ( E ) CD3 recruitment into the IS vs. KCNE4 intensity. The horizontal red line represents the threshold level (1.5) for Kv1.3 and CD3 accumulation in the IS. Values greater or less than 1.5 indicated positive or negative accumulation of proteins at the IS, respectively.
Figure Legend Snippet: KCNE4 impaired Kv1.3 accumulation in the IS but did not disrupt IS formation. Human Jurkat T lymphocytes and human Raji B lymphocytes were used to generate cell conjugates. ( A – C ) Activated B-cells (10 µg/mL SEE toxin) were cocultured in the absence ( Ba – Bd ) or presence ( Ca – Cd ) of Jurkat cells, and confocal images were obtained. ( Aa – Ad ) Jurkat T-cells in the absence of B cells. Endogenous Kv1.3 (green), CD3 (marker of T-cells, red), and CD19 (marker of B-cells, blue) were detected. ( Ad , Bd , Cd ) merge panels. Note that triple colocalization (white) in Cd localizes Kv1.3 in the IS, as identified by CD3 staining ( Cb ). Bars are 20 µm. ( D ) Accumulation ratio of mGFP-Kv1.3 at the IS vs. KCNE4-mCherry total intensity (n = 40). ( E ) CD3 recruitment into the IS vs. KCNE4 intensity. The horizontal red line represents the threshold level (1.5) for Kv1.3 and CD3 accumulation in the IS. Values greater or less than 1.5 indicated positive or negative accumulation of proteins at the IS, respectively.

Techniques Used: Marker, Staining

KCNE4 expression impairs Kv1.3 surface expression and inhibits Kv currents in Jurkat T cells. Confocal imaging of Jurkat T cells transfected with YFP, Kv1.3YFP, KCNE4CFP and KCNE4CFP with YFP-Kv1.3. Nuclei were stained with DAPI (blue). ( Aa – Ad ) Jurkat nontransfected cells (control). ( Ba – Bd ) YFP-transfected cells (YFP). ( Ca – Cd ) Kv1.3YFP transfected cells. ( Da – Dd ) KCNE4CFP transfected cells. ( Ea – Ed ) Kv1.3YFP and KCNE4CFP cotransfected cells. ( Aa , Ba , Ca , Da , Ea ) Kv1.3 in green. ( Ab , Bb , Cb , Db , Eb ) KCNE4 in red. ( Ac , Bc , Cc , Dc , Ec ) DAPI in blue. Merged yellow indicates colocalization between green and red ( Ad , Bd , Cd , Dd , Ed ). Scale bar: 5 µm. ( F ) FRET analysis of the Kv1.3-KCNE4 protein interaction by flow cytometry in Jurkat T lymphocytes. Values are mean ± SE, n = 5–7, *p
Figure Legend Snippet: KCNE4 expression impairs Kv1.3 surface expression and inhibits Kv currents in Jurkat T cells. Confocal imaging of Jurkat T cells transfected with YFP, Kv1.3YFP, KCNE4CFP and KCNE4CFP with YFP-Kv1.3. Nuclei were stained with DAPI (blue). ( Aa – Ad ) Jurkat nontransfected cells (control). ( Ba – Bd ) YFP-transfected cells (YFP). ( Ca – Cd ) Kv1.3YFP transfected cells. ( Da – Dd ) KCNE4CFP transfected cells. ( Ea – Ed ) Kv1.3YFP and KCNE4CFP cotransfected cells. ( Aa , Ba , Ca , Da , Ea ) Kv1.3 in green. ( Ab , Bb , Cb , Db , Eb ) KCNE4 in red. ( Ac , Bc , Cc , Dc , Ec ) DAPI in blue. Merged yellow indicates colocalization between green and red ( Ad , Bd , Cd , Dd , Ed ). Scale bar: 5 µm. ( F ) FRET analysis of the Kv1.3-KCNE4 protein interaction by flow cytometry in Jurkat T lymphocytes. Values are mean ± SE, n = 5–7, *p

Techniques Used: Expressing, Imaging, Transfection, Staining, Flow Cytometry

LPS-dependent activation of CY15 dendritic cells increases the abundance of Kv1.3 at the cell surface. CY15 cells were incubated in the presence (LPS) or the absence (control) of LPS for 24 h. Cells were first stained with WGA (membrane marker) and then immunolabeled against Kv1.3. ( A – D ) Control cells in the absence of LPS. ( E – H ) Cells treated with LPS. Green, Kv1.3; red, WGA; merged panels show colocalization between green and red. ( D , H ) Histogram of the pixel by pixel analysis of the section indicated by the arrow in ( C , G ), respectively. Bars represent 10 μm. ( I ) Mander's overlap coefficient (MOC) quantifying the degree of colocalization between Kv1.3 and membrane surface (WGA) staining. White bar, control; black bar, LPS. Values are mean ± SE of n > 30 cells. ***p
Figure Legend Snippet: LPS-dependent activation of CY15 dendritic cells increases the abundance of Kv1.3 at the cell surface. CY15 cells were incubated in the presence (LPS) or the absence (control) of LPS for 24 h. Cells were first stained with WGA (membrane marker) and then immunolabeled against Kv1.3. ( A – D ) Control cells in the absence of LPS. ( E – H ) Cells treated with LPS. Green, Kv1.3; red, WGA; merged panels show colocalization between green and red. ( D , H ) Histogram of the pixel by pixel analysis of the section indicated by the arrow in ( C , G ), respectively. Bars represent 10 μm. ( I ) Mander's overlap coefficient (MOC) quantifying the degree of colocalization between Kv1.3 and membrane surface (WGA) staining. White bar, control; black bar, LPS. Values are mean ± SE of n > 30 cells. ***p

Techniques Used: Activation Assay, Incubation, Staining, Whole Genome Amplification, Marker, Immunolabeling

KCNE4 overexpression modulates Kv1.3-related physiological events in Jurkat T lymphocytes. Jurkat T cells were electroporated with KCNE4CFP, and positively transfected cells were selected for specific assays. ( A ) Kv1.3 and KCNE4 expression in Jurkat cells. ( B ) Percentage of Jurkat T cell proliferation. Cells were serum starved overnight and cultured for an additional 24 h in the presence of FBS. The alamarBlue dye was used. *p
Figure Legend Snippet: KCNE4 overexpression modulates Kv1.3-related physiological events in Jurkat T lymphocytes. Jurkat T cells were electroporated with KCNE4CFP, and positively transfected cells were selected for specific assays. ( A ) Kv1.3 and KCNE4 expression in Jurkat cells. ( B ) Percentage of Jurkat T cell proliferation. Cells were serum starved overnight and cultured for an additional 24 h in the presence of FBS. The alamarBlue dye was used. *p

Techniques Used: Over Expression, Transfection, Expressing, Cell Culture

Kv1.3 and KCNE4 are differentially expressed in leukocytes. The presence of Kv1.3 and KCNE4 expression was analyzed in human Jurkat T lymphocytes and mouse CY15 dendritic cells. ( A ) Kv1.3 and KCNE4 protein expression in leukocytes. HEK 293 cells were used as a negative control. Although Jurkat and CY15 dendritic cells shared Kv1.3 and KCNE4 expression, the abundance of KCNE4 in T cells was much lower and minimally detected by western blot. In addition, Kv1.5 was abundantly expressed in CY15 cells. Representative cropped blots, clearly separated by vertical white lines, are shown only for qualitative purposes. Voltage-dependent K + currents were elicited in Jurkat ( B ) and CY15 cells ( C ). Cells were held at -60 mV, and 250 ms pulse potentials were applied as indicated. ( D ) Representative confocal images of Kv1.3 ( Da and Dd , in green) and KCNE4 ( Db and De , in red) in Jurkat T lymphocytes ( Da – Dc ) and CY15 dendritic cells ( Dd – Df ). Scale bars: 10 µm. Given the limited expression of KCNE4 in T-cells, IPI was performed in Jurkat cells. ( E ) KCNE4 coimmunoprecipitated with Kv1.3 in dendritic cells. Lysates were immunoprecipitated against Kv1.3 (IP: Kv1.3) and immunoblotted (IB) against Kv1.3 and KCNE4. Upper panel: Kv1.3. Lower panel: KCNE4. SM: starting material. SN+: supernatant from the IP+. SN−: supernatant from the IP−. IP+: Immunoprecipitation in the presence of the anti-Kv1.3 antibody. IP−: Immunoprecipitated in the absence of the anti-Kv1.3 antibody. ( F ) Kv1.3 localized in lipid raft fractions from Jurkat T-cells. ( G ) Kv1.3 and KCNE4 did not localize in lipid rafts from CY15 dendritic cells. Lipid rafts were isolated, and low density (1) to high density (12) sucrose gradient fractions were analyzed by western blot. Flotilin indicated low-buoyancy lipid rafts, whereas clathrin identified nonfloating raft fractions.
Figure Legend Snippet: Kv1.3 and KCNE4 are differentially expressed in leukocytes. The presence of Kv1.3 and KCNE4 expression was analyzed in human Jurkat T lymphocytes and mouse CY15 dendritic cells. ( A ) Kv1.3 and KCNE4 protein expression in leukocytes. HEK 293 cells were used as a negative control. Although Jurkat and CY15 dendritic cells shared Kv1.3 and KCNE4 expression, the abundance of KCNE4 in T cells was much lower and minimally detected by western blot. In addition, Kv1.5 was abundantly expressed in CY15 cells. Representative cropped blots, clearly separated by vertical white lines, are shown only for qualitative purposes. Voltage-dependent K + currents were elicited in Jurkat ( B ) and CY15 cells ( C ). Cells were held at -60 mV, and 250 ms pulse potentials were applied as indicated. ( D ) Representative confocal images of Kv1.3 ( Da and Dd , in green) and KCNE4 ( Db and De , in red) in Jurkat T lymphocytes ( Da – Dc ) and CY15 dendritic cells ( Dd – Df ). Scale bars: 10 µm. Given the limited expression of KCNE4 in T-cells, IPI was performed in Jurkat cells. ( E ) KCNE4 coimmunoprecipitated with Kv1.3 in dendritic cells. Lysates were immunoprecipitated against Kv1.3 (IP: Kv1.3) and immunoblotted (IB) against Kv1.3 and KCNE4. Upper panel: Kv1.3. Lower panel: KCNE4. SM: starting material. SN+: supernatant from the IP+. SN−: supernatant from the IP−. IP+: Immunoprecipitation in the presence of the anti-Kv1.3 antibody. IP−: Immunoprecipitated in the absence of the anti-Kv1.3 antibody. ( F ) Kv1.3 localized in lipid raft fractions from Jurkat T-cells. ( G ) Kv1.3 and KCNE4 did not localize in lipid rafts from CY15 dendritic cells. Lipid rafts were isolated, and low density (1) to high density (12) sucrose gradient fractions were analyzed by western blot. Flotilin indicated low-buoyancy lipid rafts, whereas clathrin identified nonfloating raft fractions.

Techniques Used: Expressing, Negative Control, Western Blot, Immunoprecipitation, Isolation

LPS-dependent activation increases the Kv1.3/KCNE4 ratio in CY15 dendritic cells. Cells were treated for 24 h with LPS (100 ng/ml), and the protein expression of selected K + channel proteins was studied at 0, 6 and 24 h. ( A ) Confocal images of CY15 cells stained with Kv1.3 upon LPS treatment. Scale bars: 20 µm. ( B ) Representative voltage-dependent K+ currents elicited in CY15 cells treated with (LPS 24 h) or without (LPS 0 h) LPS during 24 h. Cells were held at -60 mV and 250 ms pulses to +60 mV were applied. ( C ) Peak current densitiy (pA/pF) of K + currents from CY15 cells in the absence (0 h) or the presence (24 h) of LPS. White bars, LPS 0 h (control); black bars, LPS 24 h. Values are the mean ± SE of 4–6 cells. *p
Figure Legend Snippet: LPS-dependent activation increases the Kv1.3/KCNE4 ratio in CY15 dendritic cells. Cells were treated for 24 h with LPS (100 ng/ml), and the protein expression of selected K + channel proteins was studied at 0, 6 and 24 h. ( A ) Confocal images of CY15 cells stained with Kv1.3 upon LPS treatment. Scale bars: 20 µm. ( B ) Representative voltage-dependent K+ currents elicited in CY15 cells treated with (LPS 24 h) or without (LPS 0 h) LPS during 24 h. Cells were held at -60 mV and 250 ms pulses to +60 mV were applied. ( C ) Peak current densitiy (pA/pF) of K + currents from CY15 cells in the absence (0 h) or the presence (24 h) of LPS. White bars, LPS 0 h (control); black bars, LPS 24 h. Values are the mean ± SE of 4–6 cells. *p

Techniques Used: Activation Assay, Expressing, Staining

3) Product Images from "KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology"

Article Title: KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology

Journal: Scientific Reports

doi: 10.1038/s41598-021-94015-9

KCNE4 impaired Kv1.3 accumulation in the IS but did not disrupt IS formation. Human Jurkat T lymphocytes and human Raji B lymphocytes were used to generate cell conjugates. ( A – C ) Activated B-cells (10 µg/mL SEE toxin) were cocultured in the absence ( Ba – Bd ) or presence ( Ca – Cd ) of Jurkat cells, and confocal images were obtained. ( Aa – Ad ) Jurkat T-cells in the absence of B cells. Endogenous Kv1.3 (green), CD3 (marker of T-cells, red), and CD19 (marker of B-cells, blue) were detected. ( Ad , Bd , Cd ) merge panels. Note that triple colocalization (white) in Cd localizes Kv1.3 in the IS, as identified by CD3 staining ( Cb ). Bars are 20 µm. ( D ) Accumulation ratio of mGFP-Kv1.3 at the IS vs. KCNE4-mCherry total intensity (n = 40). ( E ) CD3 recruitment into the IS vs. KCNE4 intensity. The horizontal red line represents the threshold level (1.5) for Kv1.3 and CD3 accumulation in the IS. Values greater or less than 1.5 indicated positive or negative accumulation of proteins at the IS, respectively.
Figure Legend Snippet: KCNE4 impaired Kv1.3 accumulation in the IS but did not disrupt IS formation. Human Jurkat T lymphocytes and human Raji B lymphocytes were used to generate cell conjugates. ( A – C ) Activated B-cells (10 µg/mL SEE toxin) were cocultured in the absence ( Ba – Bd ) or presence ( Ca – Cd ) of Jurkat cells, and confocal images were obtained. ( Aa – Ad ) Jurkat T-cells in the absence of B cells. Endogenous Kv1.3 (green), CD3 (marker of T-cells, red), and CD19 (marker of B-cells, blue) were detected. ( Ad , Bd , Cd ) merge panels. Note that triple colocalization (white) in Cd localizes Kv1.3 in the IS, as identified by CD3 staining ( Cb ). Bars are 20 µm. ( D ) Accumulation ratio of mGFP-Kv1.3 at the IS vs. KCNE4-mCherry total intensity (n = 40). ( E ) CD3 recruitment into the IS vs. KCNE4 intensity. The horizontal red line represents the threshold level (1.5) for Kv1.3 and CD3 accumulation in the IS. Values greater or less than 1.5 indicated positive or negative accumulation of proteins at the IS, respectively.

Techniques Used: Marker, Staining

KCNE4 expression impairs Kv1.3 surface expression and inhibits Kv currents in Jurkat T cells. Confocal imaging of Jurkat T cells transfected with YFP, Kv1.3YFP, KCNE4CFP and KCNE4CFP with YFP-Kv1.3. Nuclei were stained with DAPI (blue). ( Aa – Ad ) Jurkat nontransfected cells (control). ( Ba – Bd ) YFP-transfected cells (YFP). ( Ca – Cd ) Kv1.3YFP transfected cells. ( Da – Dd ) KCNE4CFP transfected cells. ( Ea – Ed ) Kv1.3YFP and KCNE4CFP cotransfected cells. ( Aa , Ba , Ca , Da , Ea ) Kv1.3 in green. ( Ab , Bb , Cb , Db , Eb ) KCNE4 in red. ( Ac , Bc , Cc , Dc , Ec ) DAPI in blue. Merged yellow indicates colocalization between green and red ( Ad , Bd , Cd , Dd , Ed ). Scale bar: 5 µm. ( F ) FRET analysis of the Kv1.3-KCNE4 protein interaction by flow cytometry in Jurkat T lymphocytes. Values are mean ± SE, n = 5–7, *p
Figure Legend Snippet: KCNE4 expression impairs Kv1.3 surface expression and inhibits Kv currents in Jurkat T cells. Confocal imaging of Jurkat T cells transfected with YFP, Kv1.3YFP, KCNE4CFP and KCNE4CFP with YFP-Kv1.3. Nuclei were stained with DAPI (blue). ( Aa – Ad ) Jurkat nontransfected cells (control). ( Ba – Bd ) YFP-transfected cells (YFP). ( Ca – Cd ) Kv1.3YFP transfected cells. ( Da – Dd ) KCNE4CFP transfected cells. ( Ea – Ed ) Kv1.3YFP and KCNE4CFP cotransfected cells. ( Aa , Ba , Ca , Da , Ea ) Kv1.3 in green. ( Ab , Bb , Cb , Db , Eb ) KCNE4 in red. ( Ac , Bc , Cc , Dc , Ec ) DAPI in blue. Merged yellow indicates colocalization between green and red ( Ad , Bd , Cd , Dd , Ed ). Scale bar: 5 µm. ( F ) FRET analysis of the Kv1.3-KCNE4 protein interaction by flow cytometry in Jurkat T lymphocytes. Values are mean ± SE, n = 5–7, *p

Techniques Used: Expressing, Imaging, Transfection, Staining, Flow Cytometry

LPS-dependent activation of CY15 dendritic cells increases the abundance of Kv1.3 at the cell surface. CY15 cells were incubated in the presence (LPS) or the absence (control) of LPS for 24 h. Cells were first stained with WGA (membrane marker) and then immunolabeled against Kv1.3. ( A – D ) Control cells in the absence of LPS. ( E – H ) Cells treated with LPS. Green, Kv1.3; red, WGA; merged panels show colocalization between green and red. ( D , H ) Histogram of the pixel by pixel analysis of the section indicated by the arrow in ( C , G ), respectively. Bars represent 10 μm. ( I ) Mander's overlap coefficient (MOC) quantifying the degree of colocalization between Kv1.3 and membrane surface (WGA) staining. White bar, control; black bar, LPS. Values are mean ± SE of n > 30 cells. ***p
Figure Legend Snippet: LPS-dependent activation of CY15 dendritic cells increases the abundance of Kv1.3 at the cell surface. CY15 cells were incubated in the presence (LPS) or the absence (control) of LPS for 24 h. Cells were first stained with WGA (membrane marker) and then immunolabeled against Kv1.3. ( A – D ) Control cells in the absence of LPS. ( E – H ) Cells treated with LPS. Green, Kv1.3; red, WGA; merged panels show colocalization between green and red. ( D , H ) Histogram of the pixel by pixel analysis of the section indicated by the arrow in ( C , G ), respectively. Bars represent 10 μm. ( I ) Mander's overlap coefficient (MOC) quantifying the degree of colocalization between Kv1.3 and membrane surface (WGA) staining. White bar, control; black bar, LPS. Values are mean ± SE of n > 30 cells. ***p

Techniques Used: Activation Assay, Incubation, Staining, Whole Genome Amplification, Marker, Immunolabeling

KCNE4 overexpression modulates Kv1.3-related physiological events in Jurkat T lymphocytes. Jurkat T cells were electroporated with KCNE4CFP, and positively transfected cells were selected for specific assays. ( A ) Kv1.3 and KCNE4 expression in Jurkat cells. ( B ) Percentage of Jurkat T cell proliferation. Cells were serum starved overnight and cultured for an additional 24 h in the presence of FBS. The alamarBlue dye was used. *p
Figure Legend Snippet: KCNE4 overexpression modulates Kv1.3-related physiological events in Jurkat T lymphocytes. Jurkat T cells were electroporated with KCNE4CFP, and positively transfected cells were selected for specific assays. ( A ) Kv1.3 and KCNE4 expression in Jurkat cells. ( B ) Percentage of Jurkat T cell proliferation. Cells were serum starved overnight and cultured for an additional 24 h in the presence of FBS. The alamarBlue dye was used. *p

Techniques Used: Over Expression, Transfection, Expressing, Cell Culture

Kv1.3 and KCNE4 are differentially expressed in leukocytes. The presence of Kv1.3 and KCNE4 expression was analyzed in human Jurkat T lymphocytes and mouse CY15 dendritic cells. ( A ) Kv1.3 and KCNE4 protein expression in leukocytes. HEK 293 cells were used as a negative control. Although Jurkat and CY15 dendritic cells shared Kv1.3 and KCNE4 expression, the abundance of KCNE4 in T cells was much lower and minimally detected by western blot. In addition, Kv1.5 was abundantly expressed in CY15 cells. Representative cropped blots, clearly separated by vertical white lines, are shown only for qualitative purposes. Voltage-dependent K + currents were elicited in Jurkat ( B ) and CY15 cells ( C ). Cells were held at -60 mV, and 250 ms pulse potentials were applied as indicated. ( D ) Representative confocal images of Kv1.3 ( Da and Dd , in green) and KCNE4 ( Db and De , in red) in Jurkat T lymphocytes ( Da – Dc ) and CY15 dendritic cells ( Dd – Df ). Scale bars: 10 µm. Given the limited expression of KCNE4 in T-cells, IPI was performed in Jurkat cells. ( E ) KCNE4 coimmunoprecipitated with Kv1.3 in dendritic cells. Lysates were immunoprecipitated against Kv1.3 (IP: Kv1.3) and immunoblotted (IB) against Kv1.3 and KCNE4. Upper panel: Kv1.3. Lower panel: KCNE4. SM: starting material. SN+: supernatant from the IP+. SN−: supernatant from the IP−. IP+: Immunoprecipitation in the presence of the anti-Kv1.3 antibody. IP−: Immunoprecipitated in the absence of the anti-Kv1.3 antibody. ( F ) Kv1.3 localized in lipid raft fractions from Jurkat T-cells. ( G ) Kv1.3 and KCNE4 did not localize in lipid rafts from CY15 dendritic cells. Lipid rafts were isolated, and low density (1) to high density (12) sucrose gradient fractions were analyzed by western blot. Flotilin indicated low-buoyancy lipid rafts, whereas clathrin identified nonfloating raft fractions.
Figure Legend Snippet: Kv1.3 and KCNE4 are differentially expressed in leukocytes. The presence of Kv1.3 and KCNE4 expression was analyzed in human Jurkat T lymphocytes and mouse CY15 dendritic cells. ( A ) Kv1.3 and KCNE4 protein expression in leukocytes. HEK 293 cells were used as a negative control. Although Jurkat and CY15 dendritic cells shared Kv1.3 and KCNE4 expression, the abundance of KCNE4 in T cells was much lower and minimally detected by western blot. In addition, Kv1.5 was abundantly expressed in CY15 cells. Representative cropped blots, clearly separated by vertical white lines, are shown only for qualitative purposes. Voltage-dependent K + currents were elicited in Jurkat ( B ) and CY15 cells ( C ). Cells were held at -60 mV, and 250 ms pulse potentials were applied as indicated. ( D ) Representative confocal images of Kv1.3 ( Da and Dd , in green) and KCNE4 ( Db and De , in red) in Jurkat T lymphocytes ( Da – Dc ) and CY15 dendritic cells ( Dd – Df ). Scale bars: 10 µm. Given the limited expression of KCNE4 in T-cells, IPI was performed in Jurkat cells. ( E ) KCNE4 coimmunoprecipitated with Kv1.3 in dendritic cells. Lysates were immunoprecipitated against Kv1.3 (IP: Kv1.3) and immunoblotted (IB) against Kv1.3 and KCNE4. Upper panel: Kv1.3. Lower panel: KCNE4. SM: starting material. SN+: supernatant from the IP+. SN−: supernatant from the IP−. IP+: Immunoprecipitation in the presence of the anti-Kv1.3 antibody. IP−: Immunoprecipitated in the absence of the anti-Kv1.3 antibody. ( F ) Kv1.3 localized in lipid raft fractions from Jurkat T-cells. ( G ) Kv1.3 and KCNE4 did not localize in lipid rafts from CY15 dendritic cells. Lipid rafts were isolated, and low density (1) to high density (12) sucrose gradient fractions were analyzed by western blot. Flotilin indicated low-buoyancy lipid rafts, whereas clathrin identified nonfloating raft fractions.

Techniques Used: Expressing, Negative Control, Western Blot, Immunoprecipitation, Isolation

LPS-dependent activation increases the Kv1.3/KCNE4 ratio in CY15 dendritic cells. Cells were treated for 24 h with LPS (100 ng/ml), and the protein expression of selected K + channel proteins was studied at 0, 6 and 24 h. ( A ) Confocal images of CY15 cells stained with Kv1.3 upon LPS treatment. Scale bars: 20 µm. ( B ) Representative voltage-dependent K+ currents elicited in CY15 cells treated with (LPS 24 h) or without (LPS 0 h) LPS during 24 h. Cells were held at -60 mV and 250 ms pulses to +60 mV were applied. ( C ) Peak current densitiy (pA/pF) of K + currents from CY15 cells in the absence (0 h) or the presence (24 h) of LPS. White bars, LPS 0 h (control); black bars, LPS 24 h. Values are the mean ± SE of 4–6 cells. *p
Figure Legend Snippet: LPS-dependent activation increases the Kv1.3/KCNE4 ratio in CY15 dendritic cells. Cells were treated for 24 h with LPS (100 ng/ml), and the protein expression of selected K + channel proteins was studied at 0, 6 and 24 h. ( A ) Confocal images of CY15 cells stained with Kv1.3 upon LPS treatment. Scale bars: 20 µm. ( B ) Representative voltage-dependent K+ currents elicited in CY15 cells treated with (LPS 24 h) or without (LPS 0 h) LPS during 24 h. Cells were held at -60 mV and 250 ms pulses to +60 mV were applied. ( C ) Peak current densitiy (pA/pF) of K + currents from CY15 cells in the absence (0 h) or the presence (24 h) of LPS. White bars, LPS 0 h (control); black bars, LPS 24 h. Values are the mean ± SE of 4–6 cells. *p

Techniques Used: Activation Assay, Expressing, Staining

4) Product Images from "KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology"

Article Title: KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology

Journal: Scientific Reports

doi: 10.1038/s41598-021-94015-9

KCNE4 impaired Kv1.3 accumulation in the IS but did not disrupt IS formation. Human Jurkat T lymphocytes and human Raji B lymphocytes were used to generate cell conjugates. ( A – C ) Activated B-cells (10 µg/mL SEE toxin) were cocultured in the absence ( Ba – Bd ) or presence ( Ca – Cd ) of Jurkat cells, and confocal images were obtained. ( Aa – Ad ) Jurkat T-cells in the absence of B cells. Endogenous Kv1.3 (green), CD3 (marker of T-cells, red), and CD19 (marker of B-cells, blue) were detected. ( Ad , Bd , Cd ) merge panels. Note that triple colocalization (white) in Cd localizes Kv1.3 in the IS, as identified by CD3 staining ( Cb ). Bars are 20 µm. ( D ) Accumulation ratio of mGFP-Kv1.3 at the IS vs. KCNE4-mCherry total intensity (n = 40). ( E ) CD3 recruitment into the IS vs. KCNE4 intensity. The horizontal red line represents the threshold level (1.5) for Kv1.3 and CD3 accumulation in the IS. Values greater or less than 1.5 indicated positive or negative accumulation of proteins at the IS, respectively.
Figure Legend Snippet: KCNE4 impaired Kv1.3 accumulation in the IS but did not disrupt IS formation. Human Jurkat T lymphocytes and human Raji B lymphocytes were used to generate cell conjugates. ( A – C ) Activated B-cells (10 µg/mL SEE toxin) were cocultured in the absence ( Ba – Bd ) or presence ( Ca – Cd ) of Jurkat cells, and confocal images were obtained. ( Aa – Ad ) Jurkat T-cells in the absence of B cells. Endogenous Kv1.3 (green), CD3 (marker of T-cells, red), and CD19 (marker of B-cells, blue) were detected. ( Ad , Bd , Cd ) merge panels. Note that triple colocalization (white) in Cd localizes Kv1.3 in the IS, as identified by CD3 staining ( Cb ). Bars are 20 µm. ( D ) Accumulation ratio of mGFP-Kv1.3 at the IS vs. KCNE4-mCherry total intensity (n = 40). ( E ) CD3 recruitment into the IS vs. KCNE4 intensity. The horizontal red line represents the threshold level (1.5) for Kv1.3 and CD3 accumulation in the IS. Values greater or less than 1.5 indicated positive or negative accumulation of proteins at the IS, respectively.

Techniques Used: Marker, Staining

KCNE4 expression impairs Kv1.3 surface expression and inhibits Kv currents in Jurkat T cells. Confocal imaging of Jurkat T cells transfected with YFP, Kv1.3YFP, KCNE4CFP and KCNE4CFP with YFP-Kv1.3. Nuclei were stained with DAPI (blue). ( Aa – Ad ) Jurkat nontransfected cells (control). ( Ba – Bd ) YFP-transfected cells (YFP). ( Ca – Cd ) Kv1.3YFP transfected cells. ( Da – Dd ) KCNE4CFP transfected cells. ( Ea – Ed ) Kv1.3YFP and KCNE4CFP cotransfected cells. ( Aa , Ba , Ca , Da , Ea ) Kv1.3 in green. ( Ab , Bb , Cb , Db , Eb ) KCNE4 in red. ( Ac , Bc , Cc , Dc , Ec ) DAPI in blue. Merged yellow indicates colocalization between green and red ( Ad , Bd , Cd , Dd , Ed ). Scale bar: 5 µm. ( F ) FRET analysis of the Kv1.3-KCNE4 protein interaction by flow cytometry in Jurkat T lymphocytes. Values are mean ± SE, n = 5–7, *p
Figure Legend Snippet: KCNE4 expression impairs Kv1.3 surface expression and inhibits Kv currents in Jurkat T cells. Confocal imaging of Jurkat T cells transfected with YFP, Kv1.3YFP, KCNE4CFP and KCNE4CFP with YFP-Kv1.3. Nuclei were stained with DAPI (blue). ( Aa – Ad ) Jurkat nontransfected cells (control). ( Ba – Bd ) YFP-transfected cells (YFP). ( Ca – Cd ) Kv1.3YFP transfected cells. ( Da – Dd ) KCNE4CFP transfected cells. ( Ea – Ed ) Kv1.3YFP and KCNE4CFP cotransfected cells. ( Aa , Ba , Ca , Da , Ea ) Kv1.3 in green. ( Ab , Bb , Cb , Db , Eb ) KCNE4 in red. ( Ac , Bc , Cc , Dc , Ec ) DAPI in blue. Merged yellow indicates colocalization between green and red ( Ad , Bd , Cd , Dd , Ed ). Scale bar: 5 µm. ( F ) FRET analysis of the Kv1.3-KCNE4 protein interaction by flow cytometry in Jurkat T lymphocytes. Values are mean ± SE, n = 5–7, *p

Techniques Used: Expressing, Imaging, Transfection, Staining, Flow Cytometry

LPS-dependent activation of CY15 dendritic cells increases the abundance of Kv1.3 at the cell surface. CY15 cells were incubated in the presence (LPS) or the absence (control) of LPS for 24 h. Cells were first stained with WGA (membrane marker) and then immunolabeled against Kv1.3. ( A – D ) Control cells in the absence of LPS. ( E – H ) Cells treated with LPS. Green, Kv1.3; red, WGA; merged panels show colocalization between green and red. ( D , H ) Histogram of the pixel by pixel analysis of the section indicated by the arrow in ( C , G ), respectively. Bars represent 10 μm. ( I ) Mander's overlap coefficient (MOC) quantifying the degree of colocalization between Kv1.3 and membrane surface (WGA) staining. White bar, control; black bar, LPS. Values are mean ± SE of n > 30 cells. ***p
Figure Legend Snippet: LPS-dependent activation of CY15 dendritic cells increases the abundance of Kv1.3 at the cell surface. CY15 cells were incubated in the presence (LPS) or the absence (control) of LPS for 24 h. Cells were first stained with WGA (membrane marker) and then immunolabeled against Kv1.3. ( A – D ) Control cells in the absence of LPS. ( E – H ) Cells treated with LPS. Green, Kv1.3; red, WGA; merged panels show colocalization between green and red. ( D , H ) Histogram of the pixel by pixel analysis of the section indicated by the arrow in ( C , G ), respectively. Bars represent 10 μm. ( I ) Mander's overlap coefficient (MOC) quantifying the degree of colocalization between Kv1.3 and membrane surface (WGA) staining. White bar, control; black bar, LPS. Values are mean ± SE of n > 30 cells. ***p

Techniques Used: Activation Assay, Incubation, Staining, Whole Genome Amplification, Marker, Immunolabeling

KCNE4 overexpression modulates Kv1.3-related physiological events in Jurkat T lymphocytes. Jurkat T cells were electroporated with KCNE4CFP, and positively transfected cells were selected for specific assays. ( A ) Kv1.3 and KCNE4 expression in Jurkat cells. ( B ) Percentage of Jurkat T cell proliferation. Cells were serum starved overnight and cultured for an additional 24 h in the presence of FBS. The alamarBlue dye was used. *p
Figure Legend Snippet: KCNE4 overexpression modulates Kv1.3-related physiological events in Jurkat T lymphocytes. Jurkat T cells were electroporated with KCNE4CFP, and positively transfected cells were selected for specific assays. ( A ) Kv1.3 and KCNE4 expression in Jurkat cells. ( B ) Percentage of Jurkat T cell proliferation. Cells were serum starved overnight and cultured for an additional 24 h in the presence of FBS. The alamarBlue dye was used. *p

Techniques Used: Over Expression, Transfection, Expressing, Cell Culture

Kv1.3 and KCNE4 are differentially expressed in leukocytes. The presence of Kv1.3 and KCNE4 expression was analyzed in human Jurkat T lymphocytes and mouse CY15 dendritic cells. ( A ) Kv1.3 and KCNE4 protein expression in leukocytes. HEK 293 cells were used as a negative control. Although Jurkat and CY15 dendritic cells shared Kv1.3 and KCNE4 expression, the abundance of KCNE4 in T cells was much lower and minimally detected by western blot. In addition, Kv1.5 was abundantly expressed in CY15 cells. Representative cropped blots, clearly separated by vertical white lines, are shown only for qualitative purposes. Voltage-dependent K + currents were elicited in Jurkat ( B ) and CY15 cells ( C ). Cells were held at -60 mV, and 250 ms pulse potentials were applied as indicated. ( D ) Representative confocal images of Kv1.3 ( Da and Dd , in green) and KCNE4 ( Db and De , in red) in Jurkat T lymphocytes ( Da – Dc ) and CY15 dendritic cells ( Dd – Df ). Scale bars: 10 µm. Given the limited expression of KCNE4 in T-cells, IPI was performed in Jurkat cells. ( E ) KCNE4 coimmunoprecipitated with Kv1.3 in dendritic cells. Lysates were immunoprecipitated against Kv1.3 (IP: Kv1.3) and immunoblotted (IB) against Kv1.3 and KCNE4. Upper panel: Kv1.3. Lower panel: KCNE4. SM: starting material. SN+: supernatant from the IP+. SN−: supernatant from the IP−. IP+: Immunoprecipitation in the presence of the anti-Kv1.3 antibody. IP−: Immunoprecipitated in the absence of the anti-Kv1.3 antibody. ( F ) Kv1.3 localized in lipid raft fractions from Jurkat T-cells. ( G ) Kv1.3 and KCNE4 did not localize in lipid rafts from CY15 dendritic cells. Lipid rafts were isolated, and low density (1) to high density (12) sucrose gradient fractions were analyzed by western blot. Flotilin indicated low-buoyancy lipid rafts, whereas clathrin identified nonfloating raft fractions.
Figure Legend Snippet: Kv1.3 and KCNE4 are differentially expressed in leukocytes. The presence of Kv1.3 and KCNE4 expression was analyzed in human Jurkat T lymphocytes and mouse CY15 dendritic cells. ( A ) Kv1.3 and KCNE4 protein expression in leukocytes. HEK 293 cells were used as a negative control. Although Jurkat and CY15 dendritic cells shared Kv1.3 and KCNE4 expression, the abundance of KCNE4 in T cells was much lower and minimally detected by western blot. In addition, Kv1.5 was abundantly expressed in CY15 cells. Representative cropped blots, clearly separated by vertical white lines, are shown only for qualitative purposes. Voltage-dependent K + currents were elicited in Jurkat ( B ) and CY15 cells ( C ). Cells were held at -60 mV, and 250 ms pulse potentials were applied as indicated. ( D ) Representative confocal images of Kv1.3 ( Da and Dd , in green) and KCNE4 ( Db and De , in red) in Jurkat T lymphocytes ( Da – Dc ) and CY15 dendritic cells ( Dd – Df ). Scale bars: 10 µm. Given the limited expression of KCNE4 in T-cells, IPI was performed in Jurkat cells. ( E ) KCNE4 coimmunoprecipitated with Kv1.3 in dendritic cells. Lysates were immunoprecipitated against Kv1.3 (IP: Kv1.3) and immunoblotted (IB) against Kv1.3 and KCNE4. Upper panel: Kv1.3. Lower panel: KCNE4. SM: starting material. SN+: supernatant from the IP+. SN−: supernatant from the IP−. IP+: Immunoprecipitation in the presence of the anti-Kv1.3 antibody. IP−: Immunoprecipitated in the absence of the anti-Kv1.3 antibody. ( F ) Kv1.3 localized in lipid raft fractions from Jurkat T-cells. ( G ) Kv1.3 and KCNE4 did not localize in lipid rafts from CY15 dendritic cells. Lipid rafts were isolated, and low density (1) to high density (12) sucrose gradient fractions were analyzed by western blot. Flotilin indicated low-buoyancy lipid rafts, whereas clathrin identified nonfloating raft fractions.

Techniques Used: Expressing, Negative Control, Western Blot, Immunoprecipitation, Isolation

LPS-dependent activation increases the Kv1.3/KCNE4 ratio in CY15 dendritic cells. Cells were treated for 24 h with LPS (100 ng/ml), and the protein expression of selected K + channel proteins was studied at 0, 6 and 24 h. ( A ) Confocal images of CY15 cells stained with Kv1.3 upon LPS treatment. Scale bars: 20 µm. ( B ) Representative voltage-dependent K+ currents elicited in CY15 cells treated with (LPS 24 h) or without (LPS 0 h) LPS during 24 h. Cells were held at -60 mV and 250 ms pulses to +60 mV were applied. ( C ) Peak current densitiy (pA/pF) of K + currents from CY15 cells in the absence (0 h) or the presence (24 h) of LPS. White bars, LPS 0 h (control); black bars, LPS 24 h. Values are the mean ± SE of 4–6 cells. *p
Figure Legend Snippet: LPS-dependent activation increases the Kv1.3/KCNE4 ratio in CY15 dendritic cells. Cells were treated for 24 h with LPS (100 ng/ml), and the protein expression of selected K + channel proteins was studied at 0, 6 and 24 h. ( A ) Confocal images of CY15 cells stained with Kv1.3 upon LPS treatment. Scale bars: 20 µm. ( B ) Representative voltage-dependent K+ currents elicited in CY15 cells treated with (LPS 24 h) or without (LPS 0 h) LPS during 24 h. Cells were held at -60 mV and 250 ms pulses to +60 mV were applied. ( C ) Peak current densitiy (pA/pF) of K + currents from CY15 cells in the absence (0 h) or the presence (24 h) of LPS. White bars, LPS 0 h (control); black bars, LPS 24 h. Values are the mean ± SE of 4–6 cells. *p

Techniques Used: Activation Assay, Expressing, Staining

5) Product Images from "The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit"

Article Title: The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit

Journal: Journal of Cell Science

doi: 10.1242/jcs.191650

Kv1.3 and KCNE4 form functional channels in leukocytes. Endogenous expression of Kv1.3 and KCNE4 was analyzed in human Jurkat T-lymphocytes and mouse CY15 dendritic cells. Endogenous voltage-dependent K + currents were elicited in Jurkat (A) and CY15 cells (B). Cells were held at −60 mV, and pulse potentials were applied as indicated. Cumulative inactivation of K + currents was elicited in Jurkat (C) and CY15 cells (D) by a train of 15 depolarizing 250 ms pulses ranging from −80 mV to +60 mV once every 1 s. (E) K + currents elicited in Jurkat (left axis) and CY15 cells (right axis) at the peak current density (+80 mV) in the presence or the absence of 1 and 10 nM MgTx. Black bars, Jurkat T-cells; white bars, CY15 dendritic cells. Values are shown as the mean±s.e.m. ( n =6–8 cells/group). (F) Steady-state activation of outward K + currents. Gray circles, HEK-293 cells transfected with Kv1.3; black circles, Jurkat cells; white circles, CY15 cells. Values are shown as the mean±s.e.m. ( n =4–6 independent cells). (G) Protein expression of Kv1.3, Kv1.5 and KCNE4 in leukocytes as determined by western blotting. HEK-293 cells were used as a negative control. Notably, although Jurkat and CY15 dendritic cells express both Kv1.3 and KCNE4, the abundance of KCNE4 and Kv1.5 is much lower in T-cells and was barely detected. (H) Representative confocal images of Kv1.3 and KCNE4 in Jurkat T-lymphocytes and CY15 dendritic cells. Scale bars: 10 µm. (I) KCNE4 co-immunoprecipitates with Kv1.3 in dendritic cells. Western blots from Kv1.3 and KCNE4 co-immunoprecipitation. Lysates were immunoprecipitated for Kv1.3 (IP: Kv1.3). Upper panel: Kv1.3 immunoblot (IB: Kv1.3). Lower panel: KCNE4 immunoblot (IB: KCNE4). SM, starting material (input); IP+, immunoprecipitation in the presence of the anti-Kv1.3 antibody; IP−, immunoprecipitation in the absence of the anti-Kv1.3 antibody; SN+, supernatant from the IP+; SN−, supernatant from the IP−.
Figure Legend Snippet: Kv1.3 and KCNE4 form functional channels in leukocytes. Endogenous expression of Kv1.3 and KCNE4 was analyzed in human Jurkat T-lymphocytes and mouse CY15 dendritic cells. Endogenous voltage-dependent K + currents were elicited in Jurkat (A) and CY15 cells (B). Cells were held at −60 mV, and pulse potentials were applied as indicated. Cumulative inactivation of K + currents was elicited in Jurkat (C) and CY15 cells (D) by a train of 15 depolarizing 250 ms pulses ranging from −80 mV to +60 mV once every 1 s. (E) K + currents elicited in Jurkat (left axis) and CY15 cells (right axis) at the peak current density (+80 mV) in the presence or the absence of 1 and 10 nM MgTx. Black bars, Jurkat T-cells; white bars, CY15 dendritic cells. Values are shown as the mean±s.e.m. ( n =6–8 cells/group). (F) Steady-state activation of outward K + currents. Gray circles, HEK-293 cells transfected with Kv1.3; black circles, Jurkat cells; white circles, CY15 cells. Values are shown as the mean±s.e.m. ( n =4–6 independent cells). (G) Protein expression of Kv1.3, Kv1.5 and KCNE4 in leukocytes as determined by western blotting. HEK-293 cells were used as a negative control. Notably, although Jurkat and CY15 dendritic cells express both Kv1.3 and KCNE4, the abundance of KCNE4 and Kv1.5 is much lower in T-cells and was barely detected. (H) Representative confocal images of Kv1.3 and KCNE4 in Jurkat T-lymphocytes and CY15 dendritic cells. Scale bars: 10 µm. (I) KCNE4 co-immunoprecipitates with Kv1.3 in dendritic cells. Western blots from Kv1.3 and KCNE4 co-immunoprecipitation. Lysates were immunoprecipitated for Kv1.3 (IP: Kv1.3). Upper panel: Kv1.3 immunoblot (IB: Kv1.3). Lower panel: KCNE4 immunoblot (IB: KCNE4). SM, starting material (input); IP+, immunoprecipitation in the presence of the anti-Kv1.3 antibody; IP−, immunoprecipitation in the absence of the anti-Kv1.3 antibody; SN+, supernatant from the IP+; SN−, supernatant from the IP−.

Techniques Used: Functional Assay, Expressing, Activation Assay, Transfection, Western Blot, Negative Control, Immunoprecipitation

Kv1.3, but not Kv1.5, associates with KCNE4 in HEK-293 cells. KCNE4 modulates Kv1.3 trafficking and activity. HEK-293 cells were transfected with Kv1.3–YFP or Kv1.5–YFP in the presence or absence of KCNE4–CFP. Confocal images of (A) Kv1.3–YFP, (B) Kv1.5–YFP and (C) KCNE4–CFP. (D) HEK-293 cells co-transfected with Kv1.3 and KCNE4. (E) Kv1.5 and KCNE4. Color code: green, channels; red, KCNE4; yellow in merge panels shows colocalization. Scale bars: 10 µm. Voltage-dependent K + currents were elicited in HEK-293 cells transfected with Kv1.3 (F,G) and Kv1.5 (H,I) in the absence (F,H) or the presence (G,I) of KCNE4. Cells were held at −80 mV, and pulse potentials were applied as indicated. (J) Current density versus voltage plot of outward K + currents. White circles, Kv1.3; black circles, Kv1.3+KCNE4; light gray circles, Kv1.5; dark gray circles, Kv1.5+KCNE4. Values are shown as the mean±s.e.m. ( n =6–10 independent cells). (K) Molecular association of Kv1.3 and Kv1.5 with KCNE4 as measured by FRET efficiency (%). HEK-293 cells were transfected with Kv1.3–YFP and Kv1.5–YFP in the presence of KCNE4–CFP. YFP–CFP and Kv1.3–YFP or Kv1.3–CFP were used as negative and positive controls, respectively. Values are shown as the mean±s.e.m. ( n > 25 independent cells). ** P
Figure Legend Snippet: Kv1.3, but not Kv1.5, associates with KCNE4 in HEK-293 cells. KCNE4 modulates Kv1.3 trafficking and activity. HEK-293 cells were transfected with Kv1.3–YFP or Kv1.5–YFP in the presence or absence of KCNE4–CFP. Confocal images of (A) Kv1.3–YFP, (B) Kv1.5–YFP and (C) KCNE4–CFP. (D) HEK-293 cells co-transfected with Kv1.3 and KCNE4. (E) Kv1.5 and KCNE4. Color code: green, channels; red, KCNE4; yellow in merge panels shows colocalization. Scale bars: 10 µm. Voltage-dependent K + currents were elicited in HEK-293 cells transfected with Kv1.3 (F,G) and Kv1.5 (H,I) in the absence (F,H) or the presence (G,I) of KCNE4. Cells were held at −80 mV, and pulse potentials were applied as indicated. (J) Current density versus voltage plot of outward K + currents. White circles, Kv1.3; black circles, Kv1.3+KCNE4; light gray circles, Kv1.5; dark gray circles, Kv1.5+KCNE4. Values are shown as the mean±s.e.m. ( n =6–10 independent cells). (K) Molecular association of Kv1.3 and Kv1.5 with KCNE4 as measured by FRET efficiency (%). HEK-293 cells were transfected with Kv1.3–YFP and Kv1.5–YFP in the presence of KCNE4–CFP. YFP–CFP and Kv1.3–YFP or Kv1.3–CFP were used as negative and positive controls, respectively. Values are shown as the mean±s.e.m. ( n > 25 independent cells). ** P

Techniques Used: Activity Assay, Transfection

The structure of the Kv1.3 C-terminal domain mediates the association with KCNE4. HEK-293 cells were transfected with Kv1.3 wt, various Kv1.3 truncated mutants and KCNE4. (A) Scheme representing Kv1.3 wt and the different C-terminus truncation mutants. Bars indicate the N-terminus in white (Nt), the S1–S6 transmembrane domains in black and the C-terminal domain in gray (Ct). (B) Schematic diagram of the Kv1.3 C-terminal domain highlighting some important forward trafficking signatures and the distal PDZ motif. The residues in black indicate the truncations. A unique change (A to S) between human and rodents is indicated in gray. The S6 transmembrane domain is represented as a gray barrel. The HRETE, ExExE, YMVIEE and the PDZ motifs are indicated by gray boxes. The SwissProt number, as well as the number of residues in the C-terminus, for rat, mouse and humans is also indicated. (C) Cell lysates. Immunoprecipitation of Kv1.3–YFP C-terminus mutants with anti-GFP antibody. Top panels show the immunoblot against GFP (Kv1.3). Bottom panels show the immunoblot against KCNE4 (arrow). (D) Co-immunoprecipitation (Co-IP). Cell lysates (as in C) were immunoprecipitated with anti-GFP antibody (IP Kv1.3) and immunoblotted against Kv1.3 (IB: Kv1.3, top panel) and KCNE4 (IP: KCNE4, bottom panel). Note that the anti-GFP antibody used recognizes YFP. (E) Plot of the remaining number of C-terminal residues in the Kv1.3 C-terminus truncated mutants versus the co-immunoprecipitation of KCNE4. Values (mean±s.e.m., n =4) are calculated as the logarithm (log) of co-immunoprecipitation in arbitrary units (AU) standardized to the maximum level (scored as 1) of the co-immunoprecipitation of KCNE4 with Kv1.3 wt from D. Values followed a notable linear correlation ( r 2 =0.8175) which yielded a statistical significant ( P =0.0133) Pearson’s coefficient (0.9041).
Figure Legend Snippet: The structure of the Kv1.3 C-terminal domain mediates the association with KCNE4. HEK-293 cells were transfected with Kv1.3 wt, various Kv1.3 truncated mutants and KCNE4. (A) Scheme representing Kv1.3 wt and the different C-terminus truncation mutants. Bars indicate the N-terminus in white (Nt), the S1–S6 transmembrane domains in black and the C-terminal domain in gray (Ct). (B) Schematic diagram of the Kv1.3 C-terminal domain highlighting some important forward trafficking signatures and the distal PDZ motif. The residues in black indicate the truncations. A unique change (A to S) between human and rodents is indicated in gray. The S6 transmembrane domain is represented as a gray barrel. The HRETE, ExExE, YMVIEE and the PDZ motifs are indicated by gray boxes. The SwissProt number, as well as the number of residues in the C-terminus, for rat, mouse and humans is also indicated. (C) Cell lysates. Immunoprecipitation of Kv1.3–YFP C-terminus mutants with anti-GFP antibody. Top panels show the immunoblot against GFP (Kv1.3). Bottom panels show the immunoblot against KCNE4 (arrow). (D) Co-immunoprecipitation (Co-IP). Cell lysates (as in C) were immunoprecipitated with anti-GFP antibody (IP Kv1.3) and immunoblotted against Kv1.3 (IB: Kv1.3, top panel) and KCNE4 (IP: KCNE4, bottom panel). Note that the anti-GFP antibody used recognizes YFP. (E) Plot of the remaining number of C-terminal residues in the Kv1.3 C-terminus truncated mutants versus the co-immunoprecipitation of KCNE4. Values (mean±s.e.m., n =4) are calculated as the logarithm (log) of co-immunoprecipitation in arbitrary units (AU) standardized to the maximum level (scored as 1) of the co-immunoprecipitation of KCNE4 with Kv1.3 wt from D. Values followed a notable linear correlation ( r 2 =0.8175) which yielded a statistical significant ( P =0.0133) Pearson’s coefficient (0.9041).

Techniques Used: Transfection, Immunoprecipitation, Co-Immunoprecipitation Assay

KCNE4 interacts with the C-terminal domain of Kv1.3, thereby impairing the association with the COPII anterograde trafficking mechanism. HEK-293 cells were transfected with Kv1.3 in the presence or the absence of KCNE4, Sec24D–YFP and Sar1(H79G)–HA. (A,B) Co-immunoprecipitation of Kv1.3 and Sec24D in the presence or the absence of KCNE4. (A) Expression of Sec24D, Kv1.3 and KCNE4 in starting materials (cell lysates). (B) Co-immunoprecipitations. Samples were immunoprecipitated (+IP) against Sec24D–YFP and immunoblotted (IB) against GFP (Sec24D), Kv1.3 and KCNE4. Sar1(H79G) and KCNE4 expression led to the retention of Kv1.3 in the ER. Note that KCNE4 notably impaired the association between Kv1.3 and Sec24D. In addition, KCNE4 showed a slight co-immunoprecipitation with Sec24. Note that the anti-GFP antibody used recognizes YFP. (C–H) Molecular interaction between Kv1.3 and Sec24D in the presence or the absence of KCNE4. (C–F) A representative FRET experiment for Kv1.3 and Sec24D in the presence of KCNE4. (C) Sec24D–YFP (red) in the acceptor panel. (D) Kv1.3–CFP (green) in the donor panel. (E) Colocalization is shown in yellow. (F) Magnification of the boxed area in E. Circles highlight some ROIs. Scale bar: 10 µm. (G) FRET efficiency of the Kv1.3–Sec24D interaction in the presence or the absence of Sar1(H79G) and KCNE4. YFP and CFP, and Kv1.3–CFP and Kv1.3–YFP pairs were used as negative and positive controls, respectively. Note that although FRET values between Kv1.3 and Sec24D were positive, the presence of KCNE4 triggered a larger variability. (H) Relative KCNE4 expression in arbitrary units (AU) in FRET-positive or FRET-negative ROIs. Considering the FRET between Kv1.3 and Sec24D, two types of ROI were observed. When ROI triggered clearly positive FRET, KCNE4 expression was low. However, in ROIs with no relevant FRET values, KCNE4 expression was higher. Values are shown as the mean±s.e.m. of n > 30 cells. * P
Figure Legend Snippet: KCNE4 interacts with the C-terminal domain of Kv1.3, thereby impairing the association with the COPII anterograde trafficking mechanism. HEK-293 cells were transfected with Kv1.3 in the presence or the absence of KCNE4, Sec24D–YFP and Sar1(H79G)–HA. (A,B) Co-immunoprecipitation of Kv1.3 and Sec24D in the presence or the absence of KCNE4. (A) Expression of Sec24D, Kv1.3 and KCNE4 in starting materials (cell lysates). (B) Co-immunoprecipitations. Samples were immunoprecipitated (+IP) against Sec24D–YFP and immunoblotted (IB) against GFP (Sec24D), Kv1.3 and KCNE4. Sar1(H79G) and KCNE4 expression led to the retention of Kv1.3 in the ER. Note that KCNE4 notably impaired the association between Kv1.3 and Sec24D. In addition, KCNE4 showed a slight co-immunoprecipitation with Sec24. Note that the anti-GFP antibody used recognizes YFP. (C–H) Molecular interaction between Kv1.3 and Sec24D in the presence or the absence of KCNE4. (C–F) A representative FRET experiment for Kv1.3 and Sec24D in the presence of KCNE4. (C) Sec24D–YFP (red) in the acceptor panel. (D) Kv1.3–CFP (green) in the donor panel. (E) Colocalization is shown in yellow. (F) Magnification of the boxed area in E. Circles highlight some ROIs. Scale bar: 10 µm. (G) FRET efficiency of the Kv1.3–Sec24D interaction in the presence or the absence of Sar1(H79G) and KCNE4. YFP and CFP, and Kv1.3–CFP and Kv1.3–YFP pairs were used as negative and positive controls, respectively. Note that although FRET values between Kv1.3 and Sec24D were positive, the presence of KCNE4 triggered a larger variability. (H) Relative KCNE4 expression in arbitrary units (AU) in FRET-positive or FRET-negative ROIs. Considering the FRET between Kv1.3 and Sec24D, two types of ROI were observed. When ROI triggered clearly positive FRET, KCNE4 expression was low. However, in ROIs with no relevant FRET values, KCNE4 expression was higher. Values are shown as the mean±s.e.m. of n > 30 cells. * P

Techniques Used: Transfection, Immunoprecipitation, Expressing

The KCNE4 interaction further aggravated the intracellular retention of the Kv1.3(E 483/484 I) mutant. HEK-293 cells were transfected with Kv1.3wt, Kv1.3(E 483/484 I) and KCNE4. Membrane surface labeling was performed using WGA as described in the Materials and Methods. (A–G) Representative confocal images of Kv1.3 wt in the absence (A–C) or the presence (D–G) of KCNE4. (H–N) Representative confocal images of Kv1.3(E 483/484 I) in the absence (H–J) or the presence (K–N) of KCNE4. (A,D,H,K) Kv1.3 channels in green. (E,L) KCNE4 in red. (B,F,I,M) WGA membrane staining in blue. (C,G,J,N) Color code in merged panels: Kv1.3 channels and KCNE4 colocalization, yellow; channels and membrane, cyan; triple colocalization, white. Scale bars: 10 µm. (O) Kv1.3 membrane surface expression in arbitrary units (AU) in a pixel-by-pixel analysis. Values are shown as the mean±s.e.m. of n > 25 cells. * P
Figure Legend Snippet: The KCNE4 interaction further aggravated the intracellular retention of the Kv1.3(E 483/484 I) mutant. HEK-293 cells were transfected with Kv1.3wt, Kv1.3(E 483/484 I) and KCNE4. Membrane surface labeling was performed using WGA as described in the Materials and Methods. (A–G) Representative confocal images of Kv1.3 wt in the absence (A–C) or the presence (D–G) of KCNE4. (H–N) Representative confocal images of Kv1.3(E 483/484 I) in the absence (H–J) or the presence (K–N) of KCNE4. (A,D,H,K) Kv1.3 channels in green. (E,L) KCNE4 in red. (B,F,I,M) WGA membrane staining in blue. (C,G,J,N) Color code in merged panels: Kv1.3 channels and KCNE4 colocalization, yellow; channels and membrane, cyan; triple colocalization, white. Scale bars: 10 µm. (O) Kv1.3 membrane surface expression in arbitrary units (AU) in a pixel-by-pixel analysis. Values are shown as the mean±s.e.m. of n > 25 cells. * P

Techniques Used: Mutagenesis, Transfection, Labeling, Whole Genome Amplification, Staining, Expressing

KCNE4 associates with the Kv1.3 C-terminal domain. HEK-293 cells were transfected with Kv1.3–YFP channels and KCNE4. (A–I) Confocal images from HEK-293 cells transfected with wt and mutant Kv1.3–YFP channels and KCNE4–CFP. (A,D,G) Kv1.3–YFP, Kv1.3ΔN–YFP and Kv1.3ΔC–YFP channels in green. (B,E,H) Cellular distribution of KCNE4–CFP in red. (C,F,I) Merged images show colocalization in yellow. Scale bars: 10 µm. Note that in all cases, Kv1.3 is mostly intracellular. Representative cartoons of different Kv1.3 channels are shown at the left of their respective images. The red dotted ellipse highlights the deleted domain. (J) Histogram representing the relative colocalization between Kv1.3 channels and KCNE4. Results in arbitrary units (A.U.) are the mean±s.e.m. of a pixel-by-pixel analysis on 25–40 cells. *** P
Figure Legend Snippet: KCNE4 associates with the Kv1.3 C-terminal domain. HEK-293 cells were transfected with Kv1.3–YFP channels and KCNE4. (A–I) Confocal images from HEK-293 cells transfected with wt and mutant Kv1.3–YFP channels and KCNE4–CFP. (A,D,G) Kv1.3–YFP, Kv1.3ΔN–YFP and Kv1.3ΔC–YFP channels in green. (B,E,H) Cellular distribution of KCNE4–CFP in red. (C,F,I) Merged images show colocalization in yellow. Scale bars: 10 µm. Note that in all cases, Kv1.3 is mostly intracellular. Representative cartoons of different Kv1.3 channels are shown at the left of their respective images. The red dotted ellipse highlights the deleted domain. (J) Histogram representing the relative colocalization between Kv1.3 channels and KCNE4. Results in arbitrary units (A.U.) are the mean±s.e.m. of a pixel-by-pixel analysis on 25–40 cells. *** P

Techniques Used: Transfection, Mutagenesis

The disruption of the ERRM of KCNE4 only partially counteracted the intracellular retention of Kv1.3. HEK-293 cells were transfected with Kv1.3–YFP, KCNE4–CFP and the KCNE4(ERRM)–CFP mutant. (A) Cartoon illustrating the ERRM in the C-terminal domain of KCNE4. Positive residues (R and K) in the wild-type ERRM (brown box) were mutated to alanine residues to disrupt the motif. N-term, N-terminal extracellular domain; C-term, C-terminal intracellular domain; TMD, transmembrane domain. (B–G) Confocal images of KCNE4 wt (B–D) and the KCNE4(ERRM) mutant (E–G). (B,E) KCNE4. (C,F) Membrane staining with WGA. (D,G) Merge channel. (H–O) Representative images of Kv1.3 in the presence of KCNE4 (H–K) and KCNE4(ERRM) (L–O). (H,L) Kv1.3 in green; (I,M) KCNE4 in red; (J,N) membrane in blue; (K,O) merge. Note that although Kv1.3 colocalization with KCNE4 showed marked intracellular retention in all cases, the channel reached the surface better in the presence of KCNE4(ERRM). Scale bars: 10 µm. (P) Pixel-by-pixel analysis of the relative membrane surface expression, in arbitrary units (AU), of KCNE4 (black bars) and Kv1.3 (white bars). Note that KCNE4(ERRM) showed double the KCNE4 membrane surface expression. Furthermore, Kv1.3 reached the cell surface more efficiently in the presence of KCNE4(ERRM) than with KCNE4. Values are shown as the mean±s.e.m. ( n > 25 cells). * P
Figure Legend Snippet: The disruption of the ERRM of KCNE4 only partially counteracted the intracellular retention of Kv1.3. HEK-293 cells were transfected with Kv1.3–YFP, KCNE4–CFP and the KCNE4(ERRM)–CFP mutant. (A) Cartoon illustrating the ERRM in the C-terminal domain of KCNE4. Positive residues (R and K) in the wild-type ERRM (brown box) were mutated to alanine residues to disrupt the motif. N-term, N-terminal extracellular domain; C-term, C-terminal intracellular domain; TMD, transmembrane domain. (B–G) Confocal images of KCNE4 wt (B–D) and the KCNE4(ERRM) mutant (E–G). (B,E) KCNE4. (C,F) Membrane staining with WGA. (D,G) Merge channel. (H–O) Representative images of Kv1.3 in the presence of KCNE4 (H–K) and KCNE4(ERRM) (L–O). (H,L) Kv1.3 in green; (I,M) KCNE4 in red; (J,N) membrane in blue; (K,O) merge. Note that although Kv1.3 colocalization with KCNE4 showed marked intracellular retention in all cases, the channel reached the surface better in the presence of KCNE4(ERRM). Scale bars: 10 µm. (P) Pixel-by-pixel analysis of the relative membrane surface expression, in arbitrary units (AU), of KCNE4 (black bars) and Kv1.3 (white bars). Note that KCNE4(ERRM) showed double the KCNE4 membrane surface expression. Furthermore, Kv1.3 reached the cell surface more efficiently in the presence of KCNE4(ERRM) than with KCNE4. Values are shown as the mean±s.e.m. ( n > 25 cells). * P

Techniques Used: Transfection, Mutagenesis, Staining, Whole Genome Amplification, Expressing

The C-terminus of Kv1.3, but not Kv1.5, is necessary and sufficient for the association with KCNE4. Confocal images from HEK-293 cells transfected with Kv1.3–YFP (A–C), Kv1.3NKv1.5–YFP (D–F) and Kv1.3CKv1.5–YFP (G–I) in the presence of KCNE4–CFP. All Kv1.3 channels presented an intracellular distribution, but the colocalization of Kv1.3CKv1.5 with KCNE4–CFP is 40% lower than that with Kv1.3 or Kv1.3NKv1.5. HEK-293 cells were also transfected with Kv1.5–YFP (J–L), Kv1.5NKv1.3 (M–O) and Kv1.5CKv1.3 (P–R) in the presence of KCNE4. Although all Kv1.5 channels were distributed intracellularly, notable colocalization was only observed between KCNE4 and Kv1.5CKv1.3. Cartoons on top of panels represent chimeric channels with the N- and C-terminal domains, and six transmembrane domains (boxes). Blue, Kv1.3 domains; green, Kv1.5 domains. Color code in confocal images: green, channels; red, KCNE4; yellow, colocalization in merge panels. Scale bars: 10 μm. (S) Histogram representing the relative colocalization between Kv1.3 and Kv1.5 channels and chimeras and KCNE4. Results are mean±s.e.m. ( n =25–30 independent cells). Black columns represent Kv1.3 and Kv1.3–Kv1.5 chimeras (1.3N1.5 and 1.3C1.5). White columns represent Kv1.5 and Kv1.5–Kv1.3 chimeras (1.5N1.3 and 1.5C1.3). *** P
Figure Legend Snippet: The C-terminus of Kv1.3, but not Kv1.5, is necessary and sufficient for the association with KCNE4. Confocal images from HEK-293 cells transfected with Kv1.3–YFP (A–C), Kv1.3NKv1.5–YFP (D–F) and Kv1.3CKv1.5–YFP (G–I) in the presence of KCNE4–CFP. All Kv1.3 channels presented an intracellular distribution, but the colocalization of Kv1.3CKv1.5 with KCNE4–CFP is 40% lower than that with Kv1.3 or Kv1.3NKv1.5. HEK-293 cells were also transfected with Kv1.5–YFP (J–L), Kv1.5NKv1.3 (M–O) and Kv1.5CKv1.3 (P–R) in the presence of KCNE4. Although all Kv1.5 channels were distributed intracellularly, notable colocalization was only observed between KCNE4 and Kv1.5CKv1.3. Cartoons on top of panels represent chimeric channels with the N- and C-terminal domains, and six transmembrane domains (boxes). Blue, Kv1.3 domains; green, Kv1.5 domains. Color code in confocal images: green, channels; red, KCNE4; yellow, colocalization in merge panels. Scale bars: 10 μm. (S) Histogram representing the relative colocalization between Kv1.3 and Kv1.5 channels and chimeras and KCNE4. Results are mean±s.e.m. ( n =25–30 independent cells). Black columns represent Kv1.3 and Kv1.3–Kv1.5 chimeras (1.3N1.5 and 1.3C1.5). White columns represent Kv1.5 and Kv1.5–Kv1.3 chimeras (1.5N1.3 and 1.5C1.3). *** P

Techniques Used: Transfection

6) Product Images from "The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit"

Article Title: The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit

Journal: Journal of Cell Science

doi: 10.1242/jcs.191650

Kv1.3 and KCNE4 form functional channels in leukocytes. Endogenous expression of Kv1.3 and KCNE4 was analyzed in human Jurkat T-lymphocytes and mouse CY15 dendritic cells. Endogenous voltage-dependent K + currents were elicited in Jurkat (A) and CY15 cells (B). Cells were held at −60 mV, and pulse potentials were applied as indicated. Cumulative inactivation of K + currents was elicited in Jurkat (C) and CY15 cells (D) by a train of 15 depolarizing 250 ms pulses ranging from −80 mV to +60 mV once every 1 s. (E) K + currents elicited in Jurkat (left axis) and CY15 cells (right axis) at the peak current density (+80 mV) in the presence or the absence of 1 and 10 nM MgTx. Black bars, Jurkat T-cells; white bars, CY15 dendritic cells. Values are shown as the mean±s.e.m. ( n =6–8 cells/group). (F) Steady-state activation of outward K + currents. Gray circles, HEK-293 cells transfected with Kv1.3; black circles, Jurkat cells; white circles, CY15 cells. Values are shown as the mean±s.e.m. ( n =4–6 independent cells). (G) Protein expression of Kv1.3, Kv1.5 and KCNE4 in leukocytes as determined by western blotting. HEK-293 cells were used as a negative control. Notably, although Jurkat and CY15 dendritic cells express both Kv1.3 and KCNE4, the abundance of KCNE4 and Kv1.5 is much lower in T-cells and was barely detected. (H) Representative confocal images of Kv1.3 and KCNE4 in Jurkat T-lymphocytes and CY15 dendritic cells. Scale bars: 10 µm. (I) KCNE4 co-immunoprecipitates with Kv1.3 in dendritic cells. Western blots from Kv1.3 and KCNE4 co-immunoprecipitation. Lysates were immunoprecipitated for Kv1.3 (IP: Kv1.3). Upper panel: Kv1.3 immunoblot (IB: Kv1.3). Lower panel: KCNE4 immunoblot (IB: KCNE4). SM, starting material (input); IP+, immunoprecipitation in the presence of the anti-Kv1.3 antibody; IP−, immunoprecipitation in the absence of the anti-Kv1.3 antibody; SN+, supernatant from the IP+; SN−, supernatant from the IP−.
Figure Legend Snippet: Kv1.3 and KCNE4 form functional channels in leukocytes. Endogenous expression of Kv1.3 and KCNE4 was analyzed in human Jurkat T-lymphocytes and mouse CY15 dendritic cells. Endogenous voltage-dependent K + currents were elicited in Jurkat (A) and CY15 cells (B). Cells were held at −60 mV, and pulse potentials were applied as indicated. Cumulative inactivation of K + currents was elicited in Jurkat (C) and CY15 cells (D) by a train of 15 depolarizing 250 ms pulses ranging from −80 mV to +60 mV once every 1 s. (E) K + currents elicited in Jurkat (left axis) and CY15 cells (right axis) at the peak current density (+80 mV) in the presence or the absence of 1 and 10 nM MgTx. Black bars, Jurkat T-cells; white bars, CY15 dendritic cells. Values are shown as the mean±s.e.m. ( n =6–8 cells/group). (F) Steady-state activation of outward K + currents. Gray circles, HEK-293 cells transfected with Kv1.3; black circles, Jurkat cells; white circles, CY15 cells. Values are shown as the mean±s.e.m. ( n =4–6 independent cells). (G) Protein expression of Kv1.3, Kv1.5 and KCNE4 in leukocytes as determined by western blotting. HEK-293 cells were used as a negative control. Notably, although Jurkat and CY15 dendritic cells express both Kv1.3 and KCNE4, the abundance of KCNE4 and Kv1.5 is much lower in T-cells and was barely detected. (H) Representative confocal images of Kv1.3 and KCNE4 in Jurkat T-lymphocytes and CY15 dendritic cells. Scale bars: 10 µm. (I) KCNE4 co-immunoprecipitates with Kv1.3 in dendritic cells. Western blots from Kv1.3 and KCNE4 co-immunoprecipitation. Lysates were immunoprecipitated for Kv1.3 (IP: Kv1.3). Upper panel: Kv1.3 immunoblot (IB: Kv1.3). Lower panel: KCNE4 immunoblot (IB: KCNE4). SM, starting material (input); IP+, immunoprecipitation in the presence of the anti-Kv1.3 antibody; IP−, immunoprecipitation in the absence of the anti-Kv1.3 antibody; SN+, supernatant from the IP+; SN−, supernatant from the IP−.

Techniques Used: Functional Assay, Expressing, Mass Spectrometry, Activation Assay, Transfection, Western Blot, Negative Control, Immunoprecipitation

Kv1.3, but not Kv1.5, associates with KCNE4 in HEK-293 cells. KCNE4 modulates Kv1.3 trafficking and activity. HEK-293 cells were transfected with Kv1.3–YFP or Kv1.5–YFP in the presence or absence of KCNE4–CFP. Confocal images of (A) Kv1.3–YFP, (B) Kv1.5–YFP and (C) KCNE4–CFP. (D) HEK-293 cells co-transfected with Kv1.3 and KCNE4. (E) Kv1.5 and KCNE4. Color code: green, channels; red, KCNE4; yellow in merge panels shows colocalization. Scale bars: 10 µm. Voltage-dependent K + currents were elicited in HEK-293 cells transfected with Kv1.3 (F,G) and Kv1.5 (H,I) in the absence (F,H) or the presence (G,I) of KCNE4. Cells were held at −80 mV, and pulse potentials were applied as indicated. (J) Current density versus voltage plot of outward K + currents. White circles, Kv1.3; black circles, Kv1.3+KCNE4; light gray circles, Kv1.5; dark gray circles, Kv1.5+KCNE4. Values are shown as the mean±s.e.m. ( n =6–10 independent cells). (K) Molecular association of Kv1.3 and Kv1.5 with KCNE4 as measured by FRET efficiency (%). HEK-293 cells were transfected with Kv1.3–YFP and Kv1.5–YFP in the presence of KCNE4–CFP. YFP–CFP and Kv1.3–YFP or Kv1.3–CFP were used as negative and positive controls, respectively. Values are shown as the mean±s.e.m. ( n > 25 independent cells). ** P
Figure Legend Snippet: Kv1.3, but not Kv1.5, associates with KCNE4 in HEK-293 cells. KCNE4 modulates Kv1.3 trafficking and activity. HEK-293 cells were transfected with Kv1.3–YFP or Kv1.5–YFP in the presence or absence of KCNE4–CFP. Confocal images of (A) Kv1.3–YFP, (B) Kv1.5–YFP and (C) KCNE4–CFP. (D) HEK-293 cells co-transfected with Kv1.3 and KCNE4. (E) Kv1.5 and KCNE4. Color code: green, channels; red, KCNE4; yellow in merge panels shows colocalization. Scale bars: 10 µm. Voltage-dependent K + currents were elicited in HEK-293 cells transfected with Kv1.3 (F,G) and Kv1.5 (H,I) in the absence (F,H) or the presence (G,I) of KCNE4. Cells were held at −80 mV, and pulse potentials were applied as indicated. (J) Current density versus voltage plot of outward K + currents. White circles, Kv1.3; black circles, Kv1.3+KCNE4; light gray circles, Kv1.5; dark gray circles, Kv1.5+KCNE4. Values are shown as the mean±s.e.m. ( n =6–10 independent cells). (K) Molecular association of Kv1.3 and Kv1.5 with KCNE4 as measured by FRET efficiency (%). HEK-293 cells were transfected with Kv1.3–YFP and Kv1.5–YFP in the presence of KCNE4–CFP. YFP–CFP and Kv1.3–YFP or Kv1.3–CFP were used as negative and positive controls, respectively. Values are shown as the mean±s.e.m. ( n > 25 independent cells). ** P

Techniques Used: Activity Assay, Transfection

The structure of the Kv1.3 C-terminal domain mediates the association with KCNE4. HEK-293 cells were transfected with Kv1.3 wt, various Kv1.3 truncated mutants and KCNE4. (A) Scheme representing Kv1.3 wt and the different C-terminus truncation mutants. Bars indicate the N-terminus in white (Nt), the S1–S6 transmembrane domains in black and the C-terminal domain in gray (Ct). (B) Schematic diagram of the Kv1.3 C-terminal domain highlighting some important forward trafficking signatures and the distal PDZ motif. The residues in black indicate the truncations. A unique change (A to S) between human and rodents is indicated in gray. The S6 transmembrane domain is represented as a gray barrel. The HRETE, ExExE, YMVIEE and the PDZ motifs are indicated by gray boxes. The SwissProt number, as well as the number of residues in the C-terminus, for rat, mouse and humans is also indicated. (C) Cell lysates. Immunoprecipitation of Kv1.3–YFP C-terminus mutants with anti-GFP antibody. Top panels show the immunoblot against GFP (Kv1.3). Bottom panels show the immunoblot against KCNE4 (arrow). (D) Co-immunoprecipitation (Co-IP). Cell lysates (as in C) were immunoprecipitated with anti-GFP antibody (IP Kv1.3) and immunoblotted against Kv1.3 (IB: Kv1.3, top panel) and KCNE4 (IP: KCNE4, bottom panel). Note that the anti-GFP antibody used recognizes YFP. (E) Plot of the remaining number of C-terminal residues in the Kv1.3 C-terminus truncated mutants versus the co-immunoprecipitation of KCNE4. Values (mean±s.e.m., n =4) are calculated as the logarithm (log) of co-immunoprecipitation in arbitrary units (AU) standardized to the maximum level (scored as 1) of the co-immunoprecipitation of KCNE4 with Kv1.3 wt from D. Values followed a notable linear correlation ( r 2 =0.8175) which yielded a statistical significant ( P =0.0133) Pearson’s coefficient (0.9041).
Figure Legend Snippet: The structure of the Kv1.3 C-terminal domain mediates the association with KCNE4. HEK-293 cells were transfected with Kv1.3 wt, various Kv1.3 truncated mutants and KCNE4. (A) Scheme representing Kv1.3 wt and the different C-terminus truncation mutants. Bars indicate the N-terminus in white (Nt), the S1–S6 transmembrane domains in black and the C-terminal domain in gray (Ct). (B) Schematic diagram of the Kv1.3 C-terminal domain highlighting some important forward trafficking signatures and the distal PDZ motif. The residues in black indicate the truncations. A unique change (A to S) between human and rodents is indicated in gray. The S6 transmembrane domain is represented as a gray barrel. The HRETE, ExExE, YMVIEE and the PDZ motifs are indicated by gray boxes. The SwissProt number, as well as the number of residues in the C-terminus, for rat, mouse and humans is also indicated. (C) Cell lysates. Immunoprecipitation of Kv1.3–YFP C-terminus mutants with anti-GFP antibody. Top panels show the immunoblot against GFP (Kv1.3). Bottom panels show the immunoblot against KCNE4 (arrow). (D) Co-immunoprecipitation (Co-IP). Cell lysates (as in C) were immunoprecipitated with anti-GFP antibody (IP Kv1.3) and immunoblotted against Kv1.3 (IB: Kv1.3, top panel) and KCNE4 (IP: KCNE4, bottom panel). Note that the anti-GFP antibody used recognizes YFP. (E) Plot of the remaining number of C-terminal residues in the Kv1.3 C-terminus truncated mutants versus the co-immunoprecipitation of KCNE4. Values (mean±s.e.m., n =4) are calculated as the logarithm (log) of co-immunoprecipitation in arbitrary units (AU) standardized to the maximum level (scored as 1) of the co-immunoprecipitation of KCNE4 with Kv1.3 wt from D. Values followed a notable linear correlation ( r 2 =0.8175) which yielded a statistical significant ( P =0.0133) Pearson’s coefficient (0.9041).

Techniques Used: Transfection, Immunoprecipitation, Co-Immunoprecipitation Assay

KCNE4 interacts with the C-terminal domain of Kv1.3, thereby impairing the association with the COPII anterograde trafficking mechanism. HEK-293 cells were transfected with Kv1.3 in the presence or the absence of KCNE4, Sec24D–YFP and Sar1(H79G)–HA. (A,B) Co-immunoprecipitation of Kv1.3 and Sec24D in the presence or the absence of KCNE4. (A) Expression of Sec24D, Kv1.3 and KCNE4 in starting materials (cell lysates). (B) Co-immunoprecipitations. Samples were immunoprecipitated (+IP) against Sec24D–YFP and immunoblotted (IB) against GFP (Sec24D), Kv1.3 and KCNE4. Sar1(H79G) and KCNE4 expression led to the retention of Kv1.3 in the ER. Note that KCNE4 notably impaired the association between Kv1.3 and Sec24D. In addition, KCNE4 showed a slight co-immunoprecipitation with Sec24. Note that the anti-GFP antibody used recognizes YFP. (C–H) Molecular interaction between Kv1.3 and Sec24D in the presence or the absence of KCNE4. (C–F) A representative FRET experiment for Kv1.3 and Sec24D in the presence of KCNE4. (C) Sec24D–YFP (red) in the acceptor panel. (D) Kv1.3–CFP (green) in the donor panel. (E) Colocalization is shown in yellow. (F) Magnification of the boxed area in E. Circles highlight some ROIs. Scale bar: 10 µm. (G) FRET efficiency of the Kv1.3–Sec24D interaction in the presence or the absence of Sar1(H79G) and KCNE4. YFP and CFP, and Kv1.3–CFP and Kv1.3–YFP pairs were used as negative and positive controls, respectively. Note that although FRET values between Kv1.3 and Sec24D were positive, the presence of KCNE4 triggered a larger variability. (H) Relative KCNE4 expression in arbitrary units (AU) in FRET-positive or FRET-negative ROIs. Considering the FRET between Kv1.3 and Sec24D, two types of ROI were observed. When ROI triggered clearly positive FRET, KCNE4 expression was low. However, in ROIs with no relevant FRET values, KCNE4 expression was higher. Values are shown as the mean±s.e.m. of n > 30 cells. * P
Figure Legend Snippet: KCNE4 interacts with the C-terminal domain of Kv1.3, thereby impairing the association with the COPII anterograde trafficking mechanism. HEK-293 cells were transfected with Kv1.3 in the presence or the absence of KCNE4, Sec24D–YFP and Sar1(H79G)–HA. (A,B) Co-immunoprecipitation of Kv1.3 and Sec24D in the presence or the absence of KCNE4. (A) Expression of Sec24D, Kv1.3 and KCNE4 in starting materials (cell lysates). (B) Co-immunoprecipitations. Samples were immunoprecipitated (+IP) against Sec24D–YFP and immunoblotted (IB) against GFP (Sec24D), Kv1.3 and KCNE4. Sar1(H79G) and KCNE4 expression led to the retention of Kv1.3 in the ER. Note that KCNE4 notably impaired the association between Kv1.3 and Sec24D. In addition, KCNE4 showed a slight co-immunoprecipitation with Sec24. Note that the anti-GFP antibody used recognizes YFP. (C–H) Molecular interaction between Kv1.3 and Sec24D in the presence or the absence of KCNE4. (C–F) A representative FRET experiment for Kv1.3 and Sec24D in the presence of KCNE4. (C) Sec24D–YFP (red) in the acceptor panel. (D) Kv1.3–CFP (green) in the donor panel. (E) Colocalization is shown in yellow. (F) Magnification of the boxed area in E. Circles highlight some ROIs. Scale bar: 10 µm. (G) FRET efficiency of the Kv1.3–Sec24D interaction in the presence or the absence of Sar1(H79G) and KCNE4. YFP and CFP, and Kv1.3–CFP and Kv1.3–YFP pairs were used as negative and positive controls, respectively. Note that although FRET values between Kv1.3 and Sec24D were positive, the presence of KCNE4 triggered a larger variability. (H) Relative KCNE4 expression in arbitrary units (AU) in FRET-positive or FRET-negative ROIs. Considering the FRET between Kv1.3 and Sec24D, two types of ROI were observed. When ROI triggered clearly positive FRET, KCNE4 expression was low. However, in ROIs with no relevant FRET values, KCNE4 expression was higher. Values are shown as the mean±s.e.m. of n > 30 cells. * P

Techniques Used: Transfection, Immunoprecipitation, Expressing

The KCNE4 interaction further aggravated the intracellular retention of the Kv1.3(E 483/484 I) mutant. HEK-293 cells were transfected with Kv1.3wt, Kv1.3(E 483/484 I) and KCNE4. Membrane surface labeling was performed using WGA as described in the Materials and Methods. (A–G) Representative confocal images of Kv1.3 wt in the absence (A–C) or the presence (D–G) of KCNE4. (H–N) Representative confocal images of Kv1.3(E 483/484 I) in the absence (H–J) or the presence (K–N) of KCNE4. (A,D,H,K) Kv1.3 channels in green. (E,L) KCNE4 in red. (B,F,I,M) WGA membrane staining in blue. (C,G,J,N) Color code in merged panels: Kv1.3 channels and KCNE4 colocalization, yellow; channels and membrane, cyan; triple colocalization, white. Scale bars: 10 µm. (O) Kv1.3 membrane surface expression in arbitrary units (AU) in a pixel-by-pixel analysis. Values are shown as the mean±s.e.m. of n > 25 cells. * P
Figure Legend Snippet: The KCNE4 interaction further aggravated the intracellular retention of the Kv1.3(E 483/484 I) mutant. HEK-293 cells were transfected with Kv1.3wt, Kv1.3(E 483/484 I) and KCNE4. Membrane surface labeling was performed using WGA as described in the Materials and Methods. (A–G) Representative confocal images of Kv1.3 wt in the absence (A–C) or the presence (D–G) of KCNE4. (H–N) Representative confocal images of Kv1.3(E 483/484 I) in the absence (H–J) or the presence (K–N) of KCNE4. (A,D,H,K) Kv1.3 channels in green. (E,L) KCNE4 in red. (B,F,I,M) WGA membrane staining in blue. (C,G,J,N) Color code in merged panels: Kv1.3 channels and KCNE4 colocalization, yellow; channels and membrane, cyan; triple colocalization, white. Scale bars: 10 µm. (O) Kv1.3 membrane surface expression in arbitrary units (AU) in a pixel-by-pixel analysis. Values are shown as the mean±s.e.m. of n > 25 cells. * P

Techniques Used: Mutagenesis, Transfection, Labeling, Whole Genome Amplification, Staining, Expressing

KCNE4 associates with the Kv1.3 C-terminal domain. HEK-293 cells were transfected with Kv1.3–YFP channels and KCNE4. (A–I) Confocal images from HEK-293 cells transfected with wt and mutant Kv1.3–YFP channels and KCNE4–CFP. (A,D,G) Kv1.3–YFP, Kv1.3ΔN–YFP and Kv1.3ΔC–YFP channels in green. (B,E,H) Cellular distribution of KCNE4–CFP in red. (C,F,I) Merged images show colocalization in yellow. Scale bars: 10 µm. Note that in all cases, Kv1.3 is mostly intracellular. Representative cartoons of different Kv1.3 channels are shown at the left of their respective images. The red dotted ellipse highlights the deleted domain. (J) Histogram representing the relative colocalization between Kv1.3 channels and KCNE4. Results in arbitrary units (A.U.) are the mean±s.e.m. of a pixel-by-pixel analysis on 25–40 cells. *** P
Figure Legend Snippet: KCNE4 associates with the Kv1.3 C-terminal domain. HEK-293 cells were transfected with Kv1.3–YFP channels and KCNE4. (A–I) Confocal images from HEK-293 cells transfected with wt and mutant Kv1.3–YFP channels and KCNE4–CFP. (A,D,G) Kv1.3–YFP, Kv1.3ΔN–YFP and Kv1.3ΔC–YFP channels in green. (B,E,H) Cellular distribution of KCNE4–CFP in red. (C,F,I) Merged images show colocalization in yellow. Scale bars: 10 µm. Note that in all cases, Kv1.3 is mostly intracellular. Representative cartoons of different Kv1.3 channels are shown at the left of their respective images. The red dotted ellipse highlights the deleted domain. (J) Histogram representing the relative colocalization between Kv1.3 channels and KCNE4. Results in arbitrary units (A.U.) are the mean±s.e.m. of a pixel-by-pixel analysis on 25–40 cells. *** P

Techniques Used: Transfection, Mutagenesis

The disruption of the ERRM of KCNE4 only partially counteracted the intracellular retention of Kv1.3. HEK-293 cells were transfected with Kv1.3–YFP, KCNE4–CFP and the KCNE4(ERRM)–CFP mutant. (A) Cartoon illustrating the ERRM in the C-terminal domain of KCNE4. Positive residues (R and K) in the wild-type ERRM (brown box) were mutated to alanine residues to disrupt the motif. N-term, N-terminal extracellular domain; C-term, C-terminal intracellular domain; TMD, transmembrane domain. (B–G) Confocal images of KCNE4 wt (B–D) and the KCNE4(ERRM) mutant (E–G). (B,E) KCNE4. (C,F) Membrane staining with WGA. (D,G) Merge channel. (H–O) Representative images of Kv1.3 in the presence of KCNE4 (H–K) and KCNE4(ERRM) (L–O). (H,L) Kv1.3 in green; (I,M) KCNE4 in red; (J,N) membrane in blue; (K,O) merge. Note that although Kv1.3 colocalization with KCNE4 showed marked intracellular retention in all cases, the channel reached the surface better in the presence of KCNE4(ERRM). Scale bars: 10 µm. (P) Pixel-by-pixel analysis of the relative membrane surface expression, in arbitrary units (AU), of KCNE4 (black bars) and Kv1.3 (white bars). Note that KCNE4(ERRM) showed double the KCNE4 membrane surface expression. Furthermore, Kv1.3 reached the cell surface more efficiently in the presence of KCNE4(ERRM) than with KCNE4. Values are shown as the mean±s.e.m. ( n > 25 cells). * P
Figure Legend Snippet: The disruption of the ERRM of KCNE4 only partially counteracted the intracellular retention of Kv1.3. HEK-293 cells were transfected with Kv1.3–YFP, KCNE4–CFP and the KCNE4(ERRM)–CFP mutant. (A) Cartoon illustrating the ERRM in the C-terminal domain of KCNE4. Positive residues (R and K) in the wild-type ERRM (brown box) were mutated to alanine residues to disrupt the motif. N-term, N-terminal extracellular domain; C-term, C-terminal intracellular domain; TMD, transmembrane domain. (B–G) Confocal images of KCNE4 wt (B–D) and the KCNE4(ERRM) mutant (E–G). (B,E) KCNE4. (C,F) Membrane staining with WGA. (D,G) Merge channel. (H–O) Representative images of Kv1.3 in the presence of KCNE4 (H–K) and KCNE4(ERRM) (L–O). (H,L) Kv1.3 in green; (I,M) KCNE4 in red; (J,N) membrane in blue; (K,O) merge. Note that although Kv1.3 colocalization with KCNE4 showed marked intracellular retention in all cases, the channel reached the surface better in the presence of KCNE4(ERRM). Scale bars: 10 µm. (P) Pixel-by-pixel analysis of the relative membrane surface expression, in arbitrary units (AU), of KCNE4 (black bars) and Kv1.3 (white bars). Note that KCNE4(ERRM) showed double the KCNE4 membrane surface expression. Furthermore, Kv1.3 reached the cell surface more efficiently in the presence of KCNE4(ERRM) than with KCNE4. Values are shown as the mean±s.e.m. ( n > 25 cells). * P

Techniques Used: Transfection, Mutagenesis, Staining, Whole Genome Amplification, Expressing

The C-terminus of Kv1.3, but not Kv1.5, is necessary and sufficient for the association with KCNE4. Confocal images from HEK-293 cells transfected with Kv1.3–YFP (A–C), Kv1.3NKv1.5–YFP (D–F) and Kv1.3CKv1.5–YFP (G–I) in the presence of KCNE4–CFP. All Kv1.3 channels presented an intracellular distribution, but the colocalization of Kv1.3CKv1.5 with KCNE4–CFP is 40% lower than that with Kv1.3 or Kv1.3NKv1.5. HEK-293 cells were also transfected with Kv1.5–YFP (J–L), Kv1.5NKv1.3 (M–O) and Kv1.5CKv1.3 (P–R) in the presence of KCNE4. Although all Kv1.5 channels were distributed intracellularly, notable colocalization was only observed between KCNE4 and Kv1.5CKv1.3. Cartoons on top of panels represent chimeric channels with the N- and C-terminal domains, and six transmembrane domains (boxes). Blue, Kv1.3 domains; green, Kv1.5 domains. Color code in confocal images: green, channels; red, KCNE4; yellow, colocalization in merge panels. Scale bars: 10 μm. (S) Histogram representing the relative colocalization between Kv1.3 and Kv1.5 channels and chimeras and KCNE4. Results are mean±s.e.m. ( n =25–30 independent cells). Black columns represent Kv1.3 and Kv1.3–Kv1.5 chimeras (1.3N1.5 and 1.3C1.5). White columns represent Kv1.5 and Kv1.5–Kv1.3 chimeras (1.5N1.3 and 1.5C1.3). *** P
Figure Legend Snippet: The C-terminus of Kv1.3, but not Kv1.5, is necessary and sufficient for the association with KCNE4. Confocal images from HEK-293 cells transfected with Kv1.3–YFP (A–C), Kv1.3NKv1.5–YFP (D–F) and Kv1.3CKv1.5–YFP (G–I) in the presence of KCNE4–CFP. All Kv1.3 channels presented an intracellular distribution, but the colocalization of Kv1.3CKv1.5 with KCNE4–CFP is 40% lower than that with Kv1.3 or Kv1.3NKv1.5. HEK-293 cells were also transfected with Kv1.5–YFP (J–L), Kv1.5NKv1.3 (M–O) and Kv1.5CKv1.3 (P–R) in the presence of KCNE4. Although all Kv1.5 channels were distributed intracellularly, notable colocalization was only observed between KCNE4 and Kv1.5CKv1.3. Cartoons on top of panels represent chimeric channels with the N- and C-terminal domains, and six transmembrane domains (boxes). Blue, Kv1.3 domains; green, Kv1.5 domains. Color code in confocal images: green, channels; red, KCNE4; yellow, colocalization in merge panels. Scale bars: 10 μm. (S) Histogram representing the relative colocalization between Kv1.3 and Kv1.5 channels and chimeras and KCNE4. Results are mean±s.e.m. ( n =25–30 independent cells). Black columns represent Kv1.3 and Kv1.3–Kv1.5 chimeras (1.3N1.5 and 1.3C1.5). White columns represent Kv1.5 and Kv1.5–Kv1.3 chimeras (1.5N1.3 and 1.5C1.3). *** P

Techniques Used: Transfection

7) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

8) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

9) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

10) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

11) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

12) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

13) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

14) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

15) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

16) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

17) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

18) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

19) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

20) Product Images from "Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury"

Article Title: Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2016.06.011

Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p
Figure Legend Snippet: Callosal Kv1.3 channel protein in axons and glia is altered after injury and with CFZ treatment A. Confocal overlay showing Kv1.3 ( red ) and Kv1.2 ( green ) in rat corpus callosum 24h following midline fluid percussion TBI. Low magnification shows that each channel protein is found in reactive glia around callosal vessels (arrowheads) and along axon bundles (arrows). Inset shows paired paranodal distribution of Kv1.3 and Kv1.2 channels, some nodes with co-localization (yellow arrow), others with single channel expression (green, red arrows). B . Confocal overlays showing Kv1.3 in callosal astrocytes of sham injured (GFAP+, left-arrows; inset shows cell body and perivascular co-localization) and microglia of 24h postinjury cases (IBA1+, right-arrows). C. Western blot (WB) of protein extracts from 24h postinjury corpus callosum revealed that TBI reduced 67kD Kv1.3 levels and that CFZ treatment reversed loss of Kv1.3 expression. Data expressed as percent of paired untreated sham controls run on same blot. Lanes representative of group effects are shown in each panel. (ANOVA, *p

Techniques Used: Expressing, Western Blot

Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.
Figure Legend Snippet: Corpus callosum mixed glial cultures grown in MatTek dishes and subjected to confocal dual labeling with antibodies to Kv1.3 (green) and microglial marker protein IBA1 (red) or astrocyte marker protein GFAP (red) A. Microglia are predominantly ramified in untreated cultures (arrowhead), shifting to reactive rounded cells with lobular processes after LPS (arrows). Kv1.3 protein is localized within the majority of microglia in each field and shifts from a normal concentration around nuclei (inset, UNT), to a more uniform distribution after inflammatory stimulation (inset, LPS). B. Astrocytes show mixed flat and fibrous morphologies. Kv1.3 signal is much reduced in astrocytes relative to surrounding microglia (not stained in these images) and predominantly found in small aggregates around cell nuclei (arrow). Astrocytes do not show LPS group differences in Kv1.3 expression. Bars= 20 µm.

Techniques Used: Labeling, Marker, Concentration Assay, Staining, Expressing

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88
    NeuroMab kv1 3
    Cartoon representing the structural <t>Kv1.3-associated</t> proteins in the T-lymphocyte immunological synapse. The Kv1.3 channelosome merges a number of proteins modulating channel function at the IS during immunological synapses. PSD95 (also named synapse-associated protein 90; SAP90), which is encoded by the hDLG4 (discs large homolog 4) gene, stabilizes Kv1.3 at the IS. SAP97 (synapse-associated protein 97; hDlg1 ) plays similar roles. Therefore, SAP peptides bind to the PDZ domain in the C-terminus of Kv1.3, coupling p56lck to CD4. Kvβ2 links the N-terminus of the Kv1.3 channel to the ZIP1/2 protein, which may interact with several partners, such as p56lck and PKC. CD3 and Kv1.3 are in molecular proximity, and the channel interacts with β1-integrins. Our data indicate that ~ 10% of Kvβ2 targets to lipid rafts either associated or not with Kv1.3 and situate palmitoylated Kvβ2 (red sparkline) at the IS, independent of the Kv1.3 interaction, and stabilized by PSD95. Kvβ2 may link cellular metabolic activity and redox state with calcium signaling in lymphocytes. Kvβ2 also serves as a bridge with ZIP-1/2, which also links the complex to p56lck. Other proteins within IS are the T-cell receptor (TCR), CD3 and CD4 accessory proteins. Kvβ2 in activated T cells concentrates on the IS during synapse formation. Under proliferation, Kvβ2 targets lipid rafts, which are concentrated at the IS. In contrast, PKC activation triggers a lipid raft displacement of Kvβ2, which PSD95 counteracts
    Kv1 3, supplied by NeuroMab, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kv1 3/product/NeuroMab
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    kv1 3 - by Bioz Stars, 2022-11
    88/100 stars
      Buy from Supplier

    88
    NeuroMab anti kv1 3
    Cytosolic HSP70 and HSP90 chaperones assist with <t>Kv1.3</t> mitochondrial import. HEK 293 cells were transfected with Kv1.3YFP and subsequently stained with antibodies against HSP70 and HSP90. (A–G) Representative confocal images showing colocalization between Kv1.3YFP (green) (A, E) and HSP70 (B) or HSP90 (F) (red). (C, G) The merged image shows colocalization in yellow. (D, H) Histogram showing the pixel-by-pixel analysis of the section indicated by the line in the merged Panels (C, G) . (I, J) Electron micrographs of HEK 293 cells transfected with Kv1.3YFP. Immunogold particles with sizes of 12 and 18 nm show chaperones (white arrowheads) and Kv1.3 (black arrowheads), respectively. (I) HSP70; (J) HSP90. Scale bars represent 200 nm. (K) HEK 293 cells transfected with Kv1.3YFP were treated with DMSO (vehicle), 20 μM VER-155008 (HSP70 inhibitor) or 1 μM 17-DMAG (HSP90 inhibitor) for 18 h Next, mitochondria were purified, and the YFP intensity was analyzed using flow cytometry. Media (DMEM) and untransfected mitochondria were used as negative controls. (L) Quantification of relative mitochondrial Kv1.3YFP expression upon the indicated treatments. Data are presented as the means ± SE of 3 independent experiments. *p
    Anti Kv1 3, supplied by NeuroMab, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti kv1 3/product/NeuroMab
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti kv1 3 - by Bioz Stars, 2022-11
    88/100 stars
      Buy from Supplier

    88
    NeuroMab antibodies against kv1 3
    <t>Kv1.3</t> accumulates at perinuclear mitochondria during the G1/S transition. ( A ) Subcellular fractionation of 3T3-L1 wild-type preadipocytes to obtain the membranous (Mb) and mitochondrial (Mit) fractions. The samples were probed for Kv1.3, Na+/K+ ATPase (a membrane marker) and TIMM50 (a mitochondrial marker). ( B ) Electron micrograph showing mitochondria of 3T3-L1 wild-type preadipocytes. Kv1.3 was labeled with 18 nm immunogold particles (black arrowhead) and was located at the inner mitochondrial membrane. The scale bar represents 200 nm. ( C – H ) Cells were either in the G0/G1 or the G1/S phase following serum deprivation or serum readdition for 12 h, respectively. Representative confocal images showing Kv1.3 and mitochondria in wild-type preadipocytes fixed in the G0/G1 ( C – E ) and G1/S ( F – H ) phase. Ea-Eb and Ha-Hb are magnified images of E and H, respectively. Ea and Ha show distal regions, and Eb and Hb show perinuclear regions. Yellow indicates colocalization of Kv1.3 (green) and mitochondria (red). The scale bar represents 20 µm. ( I ) Pearson’s coefficient of colocalization between Kv1.3 and mitochondria. The data are the mean ± SE ( n > 30). *** p
    Antibodies Against Kv1 3, supplied by NeuroMab, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against kv1 3/product/NeuroMab
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibodies against kv1 3 - by Bioz Stars, 2022-11
    88/100 stars
      Buy from Supplier

    Image Search Results


    Cartoon representing the structural Kv1.3-associated proteins in the T-lymphocyte immunological synapse. The Kv1.3 channelosome merges a number of proteins modulating channel function at the IS during immunological synapses. PSD95 (also named synapse-associated protein 90; SAP90), which is encoded by the hDLG4 (discs large homolog 4) gene, stabilizes Kv1.3 at the IS. SAP97 (synapse-associated protein 97; hDlg1 ) plays similar roles. Therefore, SAP peptides bind to the PDZ domain in the C-terminus of Kv1.3, coupling p56lck to CD4. Kvβ2 links the N-terminus of the Kv1.3 channel to the ZIP1/2 protein, which may interact with several partners, such as p56lck and PKC. CD3 and Kv1.3 are in molecular proximity, and the channel interacts with β1-integrins. Our data indicate that ~ 10% of Kvβ2 targets to lipid rafts either associated or not with Kv1.3 and situate palmitoylated Kvβ2 (red sparkline) at the IS, independent of the Kv1.3 interaction, and stabilized by PSD95. Kvβ2 may link cellular metabolic activity and redox state with calcium signaling in lymphocytes. Kvβ2 also serves as a bridge with ZIP-1/2, which also links the complex to p56lck. Other proteins within IS are the T-cell receptor (TCR), CD3 and CD4 accessory proteins. Kvβ2 in activated T cells concentrates on the IS during synapse formation. Under proliferation, Kvβ2 targets lipid rafts, which are concentrated at the IS. In contrast, PKC activation triggers a lipid raft displacement of Kvβ2, which PSD95 counteracts

    Journal: Cellular and Molecular Life Sciences

    Article Title: S-acylation-dependent membrane microdomain localization of the regulatory Kvβ2.1 subunit

    doi: 10.1007/s00018-022-04269-3

    Figure Lengend Snippet: Cartoon representing the structural Kv1.3-associated proteins in the T-lymphocyte immunological synapse. The Kv1.3 channelosome merges a number of proteins modulating channel function at the IS during immunological synapses. PSD95 (also named synapse-associated protein 90; SAP90), which is encoded by the hDLG4 (discs large homolog 4) gene, stabilizes Kv1.3 at the IS. SAP97 (synapse-associated protein 97; hDlg1 ) plays similar roles. Therefore, SAP peptides bind to the PDZ domain in the C-terminus of Kv1.3, coupling p56lck to CD4. Kvβ2 links the N-terminus of the Kv1.3 channel to the ZIP1/2 protein, which may interact with several partners, such as p56lck and PKC. CD3 and Kv1.3 are in molecular proximity, and the channel interacts with β1-integrins. Our data indicate that ~ 10% of Kvβ2 targets to lipid rafts either associated or not with Kv1.3 and situate palmitoylated Kvβ2 (red sparkline) at the IS, independent of the Kv1.3 interaction, and stabilized by PSD95. Kvβ2 may link cellular metabolic activity and redox state with calcium signaling in lymphocytes. Kvβ2 also serves as a bridge with ZIP-1/2, which also links the complex to p56lck. Other proteins within IS are the T-cell receptor (TCR), CD3 and CD4 accessory proteins. Kvβ2 in activated T cells concentrates on the IS during synapse formation. Under proliferation, Kvβ2 targets lipid rafts, which are concentrated at the IS. In contrast, PKC activation triggers a lipid raft displacement of Kvβ2, which PSD95 counteracts

    Article Snippet: Filters were immunoblotted with antibodies against anti-GFP (1:1,000, Roche), Kvβ1.1 (1/1,000, NeuroMab), Kvβ2.1 (1/1,000, NeuroMab), Kv1.3 (1/200, Neuromab), β-actin (1/50,000, Sigma), ubiquitin (1/500, Santa Cruz), flotillin (1/1,000, BD Transduction), clathrin (1/1,000, BD Transduction), caveolin (1/1,000, BD transduction) or myc (1/1,000, Sigma).

    Techniques: Activity Assay, Activation Assay

    Human T lymphocytes express palmitoylated Kvβ2.1, which targets lipid raft microdomains and concentrates in the IS during the immunological response. ( A ) Human CD4 + lymphocytes express Kvβ2 and Kv1.3. T lymphocytes from 4 different donors (D1-4) were obtained and analyzed. ( B ) Kvβ2 undergoes palmitoylation in human CD4 + T-cells. SN, supernatant in the absence (−) or the presence (+) of HA. SM, starting material in the absence (−) or the presence (+) of HA. PD, pulldown of palmitoylated proteins in the absence (−) or presence (+) of HA. C Human Jurkat T lymphocytes express Kvβ2 and Kv1.3. D Kvβ2 undergoes palmitoylation in human Jurkat T cells. SM, starting material in the presence of HA. PD, pulldown of palmitoylated proteins in the presence of HA. E Proximity ligation assay (PLA) in Jurkat lymphocytes. Palmitic Alk-C16 Kvβ2 palmitoylation. Total Kvβ2 in green; Alk-C16 Kvβ2 palmitoylation in red; merged panel highlights Alk-C16 palmitoylation at the cell surface. F Kvβ2 targets lipid rafts in Jukat cells. Lipid raft fractions were sequentially extracted from the top (1, lowest density and highest buoyancy) to the bottom (12, highest density and lowest buoyancy) of the tube. Because T cells lack the expression of caveolin, flotillin identified lipid rafts. G Cell conjugates between human Jurkat T cells and human Raji B lymphocytes. (Ga-Ge) SEE-activated B lymphocytes were cocultured in the presence of Jurkat cells. Merged panel showing triple colocalization in white (white arrow) localizes Kvβ2 in the IS. Panel Ge shows the accumulation ratio of Kvβ2 at the IS vs. the entire Kvβ2 cell intensity. Values represent mean ± SE. *** p

    Journal: Cellular and Molecular Life Sciences

    Article Title: S-acylation-dependent membrane microdomain localization of the regulatory Kvβ2.1 subunit

    doi: 10.1007/s00018-022-04269-3

    Figure Lengend Snippet: Human T lymphocytes express palmitoylated Kvβ2.1, which targets lipid raft microdomains and concentrates in the IS during the immunological response. ( A ) Human CD4 + lymphocytes express Kvβ2 and Kv1.3. T lymphocytes from 4 different donors (D1-4) were obtained and analyzed. ( B ) Kvβ2 undergoes palmitoylation in human CD4 + T-cells. SN, supernatant in the absence (−) or the presence (+) of HA. SM, starting material in the absence (−) or the presence (+) of HA. PD, pulldown of palmitoylated proteins in the absence (−) or presence (+) of HA. C Human Jurkat T lymphocytes express Kvβ2 and Kv1.3. D Kvβ2 undergoes palmitoylation in human Jurkat T cells. SM, starting material in the presence of HA. PD, pulldown of palmitoylated proteins in the presence of HA. E Proximity ligation assay (PLA) in Jurkat lymphocytes. Palmitic Alk-C16 Kvβ2 palmitoylation. Total Kvβ2 in green; Alk-C16 Kvβ2 palmitoylation in red; merged panel highlights Alk-C16 palmitoylation at the cell surface. F Kvβ2 targets lipid rafts in Jukat cells. Lipid raft fractions were sequentially extracted from the top (1, lowest density and highest buoyancy) to the bottom (12, highest density and lowest buoyancy) of the tube. Because T cells lack the expression of caveolin, flotillin identified lipid rafts. G Cell conjugates between human Jurkat T cells and human Raji B lymphocytes. (Ga-Ge) SEE-activated B lymphocytes were cocultured in the presence of Jurkat cells. Merged panel showing triple colocalization in white (white arrow) localizes Kvβ2 in the IS. Panel Ge shows the accumulation ratio of Kvβ2 at the IS vs. the entire Kvβ2 cell intensity. Values represent mean ± SE. *** p

    Article Snippet: Filters were immunoblotted with antibodies against anti-GFP (1:1,000, Roche), Kvβ1.1 (1/1,000, NeuroMab), Kvβ2.1 (1/1,000, NeuroMab), Kv1.3 (1/200, Neuromab), β-actin (1/50,000, Sigma), ubiquitin (1/500, Santa Cruz), flotillin (1/1,000, BD Transduction), clathrin (1/1,000, BD Transduction), caveolin (1/1,000, BD transduction) or myc (1/1,000, Sigma).

    Techniques: Proximity Ligation Assay, Expressing

    Cytosolic HSP70 and HSP90 chaperones assist with Kv1.3 mitochondrial import. HEK 293 cells were transfected with Kv1.3YFP and subsequently stained with antibodies against HSP70 and HSP90. (A–G) Representative confocal images showing colocalization between Kv1.3YFP (green) (A, E) and HSP70 (B) or HSP90 (F) (red). (C, G) The merged image shows colocalization in yellow. (D, H) Histogram showing the pixel-by-pixel analysis of the section indicated by the line in the merged Panels (C, G) . (I, J) Electron micrographs of HEK 293 cells transfected with Kv1.3YFP. Immunogold particles with sizes of 12 and 18 nm show chaperones (white arrowheads) and Kv1.3 (black arrowheads), respectively. (I) HSP70; (J) HSP90. Scale bars represent 200 nm. (K) HEK 293 cells transfected with Kv1.3YFP were treated with DMSO (vehicle), 20 μM VER-155008 (HSP70 inhibitor) or 1 μM 17-DMAG (HSP90 inhibitor) for 18 h Next, mitochondria were purified, and the YFP intensity was analyzed using flow cytometry. Media (DMEM) and untransfected mitochondria were used as negative controls. (L) Quantification of relative mitochondrial Kv1.3YFP expression upon the indicated treatments. Data are presented as the means ± SE of 3 independent experiments. *p

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Cytosolic HSP70 and HSP90 chaperones assist with Kv1.3 mitochondrial import. HEK 293 cells were transfected with Kv1.3YFP and subsequently stained with antibodies against HSP70 and HSP90. (A–G) Representative confocal images showing colocalization between Kv1.3YFP (green) (A, E) and HSP70 (B) or HSP90 (F) (red). (C, G) The merged image shows colocalization in yellow. (D, H) Histogram showing the pixel-by-pixel analysis of the section indicated by the line in the merged Panels (C, G) . (I, J) Electron micrographs of HEK 293 cells transfected with Kv1.3YFP. Immunogold particles with sizes of 12 and 18 nm show chaperones (white arrowheads) and Kv1.3 (black arrowheads), respectively. (I) HSP70; (J) HSP90. Scale bars represent 200 nm. (K) HEK 293 cells transfected with Kv1.3YFP were treated with DMSO (vehicle), 20 μM VER-155008 (HSP70 inhibitor) or 1 μM 17-DMAG (HSP90 inhibitor) for 18 h Next, mitochondria were purified, and the YFP intensity was analyzed using flow cytometry. Media (DMEM) and untransfected mitochondria were used as negative controls. (L) Quantification of relative mitochondrial Kv1.3YFP expression upon the indicated treatments. Data are presented as the means ± SE of 3 independent experiments. *p

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Transfection, Staining, Purification, Flow Cytometry, Expressing

    Schematic representation of the mitochondrial import pathway for Kv1.3. The Kv1.3 channel is cotranslated by ER-linked and cytosolic ribosomes. ER ribosomes synthesize the plasma membrane Kv1.3, which interacts early with ancillary proteins, such as Kvβ subunits and caveolin, and is routed to the cell surface via COPII-dependent anterograde trafficking. The yellow circle restrains anterograde trafficking to the plasma membrane. Alternatively, (1) the Kv1.3 mRNA, which is translated by cytosolic ribosomes, follows the mitochondrial route. (2) By interacting with channel hydrophobic domains, cytosolic chaperones and cochaperones provide Kv1.3 with a partially folded state competent for mitochondrial translocation. Sequential transmembrane domains from the N- to C-terminus cooperate to achieve the proper folded state. (3) TOM receptors recognize cytosolic Kv1.3. (4) The TOM40 channel at the OMM translocates Kv1.3 to the TIM complex at the IMM. Finally, (5) the TIM50 receptor facilitates Kv1.3 translocation through the TIM23/17 channel into the IMM (6) . Spatial and temporal mechanisms defining Kv1.3 membrane topology and tetramerization at the IMM remain unknown.

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Schematic representation of the mitochondrial import pathway for Kv1.3. The Kv1.3 channel is cotranslated by ER-linked and cytosolic ribosomes. ER ribosomes synthesize the plasma membrane Kv1.3, which interacts early with ancillary proteins, such as Kvβ subunits and caveolin, and is routed to the cell surface via COPII-dependent anterograde trafficking. The yellow circle restrains anterograde trafficking to the plasma membrane. Alternatively, (1) the Kv1.3 mRNA, which is translated by cytosolic ribosomes, follows the mitochondrial route. (2) By interacting with channel hydrophobic domains, cytosolic chaperones and cochaperones provide Kv1.3 with a partially folded state competent for mitochondrial translocation. Sequential transmembrane domains from the N- to C-terminus cooperate to achieve the proper folded state. (3) TOM receptors recognize cytosolic Kv1.3. (4) The TOM40 channel at the OMM translocates Kv1.3 to the TIM complex at the IMM. Finally, (5) the TIM50 receptor facilitates Kv1.3 translocation through the TIM23/17 channel into the IMM (6) . Spatial and temporal mechanisms defining Kv1.3 membrane topology and tetramerization at the IMM remain unknown.

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Translocation Assay

    The Kv1.3 interactome reveals an unconventional mitochondrial import pathway for Kv1.3. (A) Network showing protein–protein interactions (PPIs) in the mitochondrial Kv1.3 interactome of HEK 293 cells transfected with Kv1.3YFP. The mitochondrial import subnetwork was obtained after a functional enrichment analysis of the Kv1.3 interactome. A force-directed layout was used for network visualization. Protein names are indicated at the node center. The color code indicates functional relations between proteins (purple, chaperones; blue, matrix proteases; red, PAM complex; orange, TIM23 complex; green, TOM complex; yellow, MICOS complex). TOMM34, CDC37 and YWHAE were manually annotated based on published evidence. (B) HEK 293 cells were transfected with Kv1.3YFP. Total cell lysates (SM, starting materials) were immunoprecipitated against Kv1.3 (IP+). IP-, absence of the Kv1.3 antibody. Samples were immunoblotted (IB) with antibodies against Kv1.3 and different TIM/TOM proteins, as indicated.

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: The Kv1.3 interactome reveals an unconventional mitochondrial import pathway for Kv1.3. (A) Network showing protein–protein interactions (PPIs) in the mitochondrial Kv1.3 interactome of HEK 293 cells transfected with Kv1.3YFP. The mitochondrial import subnetwork was obtained after a functional enrichment analysis of the Kv1.3 interactome. A force-directed layout was used for network visualization. Protein names are indicated at the node center. The color code indicates functional relations between proteins (purple, chaperones; blue, matrix proteases; red, PAM complex; orange, TIM23 complex; green, TOM complex; yellow, MICOS complex). TOMM34, CDC37 and YWHAE were manually annotated based on published evidence. (B) HEK 293 cells were transfected with Kv1.3YFP. Total cell lysates (SM, starting materials) were immunoprecipitated against Kv1.3 (IP+). IP-, absence of the Kv1.3 antibody. Samples were immunoblotted (IB) with antibodies against Kv1.3 and different TIM/TOM proteins, as indicated.

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Transfection, Functional Assay, Immunoprecipitation

    Mitochondrial targeting of Kv1.3 depends on structural information rather than on discrete motifs. HEK 293 cells were transfected with several Kv1.3-Δx channels, and mitochondrial colocalization was analyzed. (A–I) Representative confocal images of different Kv1.3YFP constructs (a, green) and the mitochondrial marker (b, pmitoRFP in red). Kv1.3-Δx indicates the transmembrane segment deleted from the expressed Kv1.3YFP construct. Kv1.3-ΔN (B) and Kv1.3-ΔC (I) indicate deletion of the N- and C-termini, respectively. Panel c (merge) shows colocalization in yellow. Square inset indicates the region shown at higher magnification. The scale bar represents 10 µm. (J) Quantification of mitochondrial colocalization using Pearson’s correlation coefficient. The dashed line highlights the Kv1.3 WT value. Data are presented as the means ± SE (n > 30). *p

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Mitochondrial targeting of Kv1.3 depends on structural information rather than on discrete motifs. HEK 293 cells were transfected with several Kv1.3-Δx channels, and mitochondrial colocalization was analyzed. (A–I) Representative confocal images of different Kv1.3YFP constructs (a, green) and the mitochondrial marker (b, pmitoRFP in red). Kv1.3-Δx indicates the transmembrane segment deleted from the expressed Kv1.3YFP construct. Kv1.3-ΔN (B) and Kv1.3-ΔC (I) indicate deletion of the N- and C-termini, respectively. Panel c (merge) shows colocalization in yellow. Square inset indicates the region shown at higher magnification. The scale bar represents 10 µm. (J) Quantification of mitochondrial colocalization using Pearson’s correlation coefficient. The dashed line highlights the Kv1.3 WT value. Data are presented as the means ± SE (n > 30). *p

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Transfection, Construct, Marker

    Transmembrane domains are candidate determinants of the mitochondrial import of Shaker channels. HEK 293 cells were transfected with Kv1.1-Kv1.5YFP channels, and mitochondrial expression was analyzed. (A) Membranous (Mb) and mitochondrial (Mit) fractions of HEK 293 cells transfected with the indicated member of the Shaker family. Note a shift in the molecular weights of the Kv1.2, Kv1.3 and Kv1.5 channels between the Mb and Mit fractions. Na + /K + ATPse is used as a plasma membrane marker, and VDAC is used as a mitochondrial marker. (B) Multiple protein sequence alignment of members of the Shaker family of voltage-gated potassium channels performed using Clustal Omega and JalView software. UniprotKB reference numbers are indicated. Hydrophobic residues are indicated in red, and hydrophilic residues are indicated in blue. Conservation among sequences is indicated in yellow. S1-S6 black lines indicate the sequence fragments corresponding to the transmembrane segments.

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Transmembrane domains are candidate determinants of the mitochondrial import of Shaker channels. HEK 293 cells were transfected with Kv1.1-Kv1.5YFP channels, and mitochondrial expression was analyzed. (A) Membranous (Mb) and mitochondrial (Mit) fractions of HEK 293 cells transfected with the indicated member of the Shaker family. Note a shift in the molecular weights of the Kv1.2, Kv1.3 and Kv1.5 channels between the Mb and Mit fractions. Na + /K + ATPse is used as a plasma membrane marker, and VDAC is used as a mitochondrial marker. (B) Multiple protein sequence alignment of members of the Shaker family of voltage-gated potassium channels performed using Clustal Omega and JalView software. UniprotKB reference numbers are indicated. Hydrophobic residues are indicated in red, and hydrophilic residues are indicated in blue. Conservation among sequences is indicated in yellow. S1-S6 black lines indicate the sequence fragments corresponding to the transmembrane segments.

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Transfection, Expressing, Marker, Sequencing, Software

    Sequential deletion of Kv1.3 segments results in differential mitochondrial targeting. HEK 293 cells were transfected with several Kv1.3-Δx channels, and mitochondrial expression was studied. (A) Representative immunoblot showing purified mitochondrial fractions (bottom panels) from total lysates (starting materials) of HEK 293 cells transfected with Kv1.3-Δx. Samples were immunoblotted with antibodies against YFP (Kv1.3), Na + /K + ATPase (membrane marker) and VDAC (mitochondrial marker). (B) Relative mitochondrial Kv1.3-Δx expression. Data are presented as the means ± SE (n=3-5). The linear regression shown in red (y=0.09568x+0.2544) had a Pearson’s correlation coefficient of r=0.8899 (p=0.0125). Kv1.3-ΔC was not included in the calculation because of its substantial mitochondrial-independent ER retention ( 23 ).

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Sequential deletion of Kv1.3 segments results in differential mitochondrial targeting. HEK 293 cells were transfected with several Kv1.3-Δx channels, and mitochondrial expression was studied. (A) Representative immunoblot showing purified mitochondrial fractions (bottom panels) from total lysates (starting materials) of HEK 293 cells transfected with Kv1.3-Δx. Samples were immunoblotted with antibodies against YFP (Kv1.3), Na + /K + ATPase (membrane marker) and VDAC (mitochondrial marker). (B) Relative mitochondrial Kv1.3-Δx expression. Data are presented as the means ± SE (n=3-5). The linear regression shown in red (y=0.09568x+0.2544) had a Pearson’s correlation coefficient of r=0.8899 (p=0.0125). Kv1.3-ΔC was not included in the calculation because of its substantial mitochondrial-independent ER retention ( 23 ).

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Transfection, Expressing, Purification, Marker

    Kv1.3 is targeted to the mitochondria by bypassing the endoplasmic reticulum. (A) Subcellular fractionation to obtain the membranous (Mb), mitochondrial (Mit) and cytosolic (Cyto) fractions of HEK 293 cells transfected with Kv1.3YFP. SM, starting materials. Na + /K + ATPase is used as a plasma membrane (PM) marker, and VDAC is used as a mitochondrial marker. β-actin identified cytosolic-enriched fractions. Note the difference in molecular weight of Kv1.3 bands from the Mb and Mit fractions. (B) Mb and Mit fractions of HEK 293 cells transfected with Kv1.3YFP were obtained. Cells were cotransfected with (+) or without (-) a constitutively active Sar1(H79G) dominant-negative GTPase. (C–H) Electron micrographs of HEK 293 cells transfected with Kv1.3YFP. Kv1.3 was labeled with 18 nm immunogold particles. Arrowheads indicate Kv1.3. (C) Plasma membrane Kv1.3. (D) Kv1.3 in the ER. (E) Kv1.3 in the Golgi (black arrowhead) and in the IMM (white arrowhead). (F–H) Black arrowheads indicate cytosolic Kv1.3, and white arrowheads indicate mitochondrial Kv1.3. Note the presence of Kv1.3 in ribosomes (r) close to a mitochondrion or embedded in the actin cytoskeleton (a) in (F, G) , respectively. The scale bar indicates 500 nm. White square insets in (C, G, H) highlight higher magnification regions with a scale bar representing 200 nm.

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Kv1.3 is targeted to the mitochondria by bypassing the endoplasmic reticulum. (A) Subcellular fractionation to obtain the membranous (Mb), mitochondrial (Mit) and cytosolic (Cyto) fractions of HEK 293 cells transfected with Kv1.3YFP. SM, starting materials. Na + /K + ATPase is used as a plasma membrane (PM) marker, and VDAC is used as a mitochondrial marker. β-actin identified cytosolic-enriched fractions. Note the difference in molecular weight of Kv1.3 bands from the Mb and Mit fractions. (B) Mb and Mit fractions of HEK 293 cells transfected with Kv1.3YFP were obtained. Cells were cotransfected with (+) or without (-) a constitutively active Sar1(H79G) dominant-negative GTPase. (C–H) Electron micrographs of HEK 293 cells transfected with Kv1.3YFP. Kv1.3 was labeled with 18 nm immunogold particles. Arrowheads indicate Kv1.3. (C) Plasma membrane Kv1.3. (D) Kv1.3 in the ER. (E) Kv1.3 in the Golgi (black arrowhead) and in the IMM (white arrowhead). (F–H) Black arrowheads indicate cytosolic Kv1.3, and white arrowheads indicate mitochondrial Kv1.3. Note the presence of Kv1.3 in ribosomes (r) close to a mitochondrion or embedded in the actin cytoskeleton (a) in (F, G) , respectively. The scale bar indicates 500 nm. White square insets in (C, G, H) highlight higher magnification regions with a scale bar representing 200 nm.

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Fractionation, Transfection, Marker, Molecular Weight, Dominant Negative Mutation, Labeling

    Transmembrane segments encode sufficient information to localize Kv1.3 to mitochondria. HEK 293 cells were transfected with several YFP-Sx(1-6) transmembrane peptides, and mitochondrial colocalization was analyzed. (A) Cartoon representing the transmembrane peptide constructs. Sx indicates the transmembrane segment (1-6) inserted in the YFP plasmid. (B–H) Representative confocal images of HEK 293 cells cotransfected with different YFP constructs (a, green) and a mitochondrial marker (b, pmitoRFP in red). The merged image (c) shows colocalization in yellow. The square inset indicates the region shown at higher magnification. The scale bar represents 10 µm. (I) Quantification of colocalization using Pearson’s correlation coefficient. Data are presented as the means ± SE (n > 30). *p

    Journal: Frontiers in Oncology

    Article Title: The Mitochondrial Routing of the Kv1.3 Channel

    doi: 10.3389/fonc.2022.865686

    Figure Lengend Snippet: Transmembrane segments encode sufficient information to localize Kv1.3 to mitochondria. HEK 293 cells were transfected with several YFP-Sx(1-6) transmembrane peptides, and mitochondrial colocalization was analyzed. (A) Cartoon representing the transmembrane peptide constructs. Sx indicates the transmembrane segment (1-6) inserted in the YFP plasmid. (B–H) Representative confocal images of HEK 293 cells cotransfected with different YFP constructs (a, green) and a mitochondrial marker (b, pmitoRFP in red). The merged image (c) shows colocalization in yellow. The square inset indicates the region shown at higher magnification. The scale bar represents 10 µm. (I) Quantification of colocalization using Pearson’s correlation coefficient. Data are presented as the means ± SE (n > 30). *p

    Article Snippet: Samples were mounted over Formvar-coated grills, and sections were finally stained with 2% uranyl acetate for 15 min. Immunolabeling was performed with primary anti-Kv1.3 (1:30, Neuromab), anti-HSP70 (1:50, Abcam) or anti-HSP90 (1:30, Abcam) antibodies.

    Techniques: Transfection, Construct, Plasmid Preparation, Marker

    Kv1.3 accumulates at perinuclear mitochondria during the G1/S transition. ( A ) Subcellular fractionation of 3T3-L1 wild-type preadipocytes to obtain the membranous (Mb) and mitochondrial (Mit) fractions. The samples were probed for Kv1.3, Na+/K+ ATPase (a membrane marker) and TIMM50 (a mitochondrial marker). ( B ) Electron micrograph showing mitochondria of 3T3-L1 wild-type preadipocytes. Kv1.3 was labeled with 18 nm immunogold particles (black arrowhead) and was located at the inner mitochondrial membrane. The scale bar represents 200 nm. ( C – H ) Cells were either in the G0/G1 or the G1/S phase following serum deprivation or serum readdition for 12 h, respectively. Representative confocal images showing Kv1.3 and mitochondria in wild-type preadipocytes fixed in the G0/G1 ( C – E ) and G1/S ( F – H ) phase. Ea-Eb and Ha-Hb are magnified images of E and H, respectively. Ea and Ha show distal regions, and Eb and Hb show perinuclear regions. Yellow indicates colocalization of Kv1.3 (green) and mitochondria (red). The scale bar represents 20 µm. ( I ) Pearson’s coefficient of colocalization between Kv1.3 and mitochondria. The data are the mean ± SE ( n > 30). *** p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 accumulates at perinuclear mitochondria during the G1/S transition. ( A ) Subcellular fractionation of 3T3-L1 wild-type preadipocytes to obtain the membranous (Mb) and mitochondrial (Mit) fractions. The samples were probed for Kv1.3, Na+/K+ ATPase (a membrane marker) and TIMM50 (a mitochondrial marker). ( B ) Electron micrograph showing mitochondria of 3T3-L1 wild-type preadipocytes. Kv1.3 was labeled with 18 nm immunogold particles (black arrowhead) and was located at the inner mitochondrial membrane. The scale bar represents 200 nm. ( C – H ) Cells were either in the G0/G1 or the G1/S phase following serum deprivation or serum readdition for 12 h, respectively. Representative confocal images showing Kv1.3 and mitochondria in wild-type preadipocytes fixed in the G0/G1 ( C – E ) and G1/S ( F – H ) phase. Ea-Eb and Ha-Hb are magnified images of E and H, respectively. Ea and Ha show distal regions, and Eb and Hb show perinuclear regions. Yellow indicates colocalization of Kv1.3 (green) and mitochondria (red). The scale bar represents 20 µm. ( I ) Pearson’s coefficient of colocalization between Kv1.3 and mitochondria. The data are the mean ± SE ( n > 30). *** p

    Article Snippet: The membranes were immunoblotted with the following specific antibodies: anti-Kv1.3 (1/200, Neuromab, Davis, CA, USA), anti-Cyclin E (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin D1 (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin A (1/200, Santa Cruz, Dallas, TX, USA), anti-β actin (1/50.000, Sigma, Saint Louis, MO, USA), anti-Glut4 (1/500, OSCRX), anti-TIMM50 (1/100, Abcam, Cambridge, UK), anti-Mtf2 (1/1000, Abcam, Cambridge, UK), anti-Drp1 (1/500, Abcam, Cambridge, UK), and anti-Na+/K+ ATPase (1/1000, Dev Studies Hybridoma Bank, University of Iowa, USA).

    Techniques: Fractionation, Marker, Labeling

    Kv1.3 regulates the mitochondrial membrane potential during the cell cycle. Ablation of Kv1.3 impairs the mitochondrial membrane potential. ( A ) TMRM intensity in wild-type (black bar) and Kv1.3KD (white bar) 3T3-L1 preadipocytes was analyzed with flow cytometry. The data are the mean ± SE ( n = 3), * p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 regulates the mitochondrial membrane potential during the cell cycle. Ablation of Kv1.3 impairs the mitochondrial membrane potential. ( A ) TMRM intensity in wild-type (black bar) and Kv1.3KD (white bar) 3T3-L1 preadipocytes was analyzed with flow cytometry. The data are the mean ± SE ( n = 3), * p

    Article Snippet: The membranes were immunoblotted with the following specific antibodies: anti-Kv1.3 (1/200, Neuromab, Davis, CA, USA), anti-Cyclin E (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin D1 (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin A (1/200, Santa Cruz, Dallas, TX, USA), anti-β actin (1/50.000, Sigma, Saint Louis, MO, USA), anti-Glut4 (1/500, OSCRX), anti-TIMM50 (1/100, Abcam, Cambridge, UK), anti-Mtf2 (1/1000, Abcam, Cambridge, UK), anti-Drp1 (1/500, Abcam, Cambridge, UK), and anti-Na+/K+ ATPase (1/1000, Dev Studies Hybridoma Bank, University of Iowa, USA).

    Techniques: Flow Cytometry

    Kv1.3 facilitates the G1/S transition of the cell cycle in preadipocytes. Serum-starved resting cells were incubated for the indicated time after serum readdition. ( A ) Cell cycle analysis of 3T3-L1 preadipocytes was performed with propidium iodide. Representative histograms at 0, 6, 12, 18 or 24 h after serum readdition. The cells exhibit two blue peaks corresponding to the G0/G1 (left) and G2 (right) phases. The cell population in purple corresponds to cells in the S phase. Left panels, wild-type preadipocytes; right panels, Kv1.3KD preadipocytes. ( B ) The % of cells in the G0/G1 phase, % of cells in the S phase and % of cells in the G2 phase for wild-type (black) and Kv1.3KD (white) preadipocytes. The data are the mean ± SE ( n = 4–10 independent experiments). Two-way ANOVA indicated p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 facilitates the G1/S transition of the cell cycle in preadipocytes. Serum-starved resting cells were incubated for the indicated time after serum readdition. ( A ) Cell cycle analysis of 3T3-L1 preadipocytes was performed with propidium iodide. Representative histograms at 0, 6, 12, 18 or 24 h after serum readdition. The cells exhibit two blue peaks corresponding to the G0/G1 (left) and G2 (right) phases. The cell population in purple corresponds to cells in the S phase. Left panels, wild-type preadipocytes; right panels, Kv1.3KD preadipocytes. ( B ) The % of cells in the G0/G1 phase, % of cells in the S phase and % of cells in the G2 phase for wild-type (black) and Kv1.3KD (white) preadipocytes. The data are the mean ± SE ( n = 4–10 independent experiments). Two-way ANOVA indicated p

    Article Snippet: The membranes were immunoblotted with the following specific antibodies: anti-Kv1.3 (1/200, Neuromab, Davis, CA, USA), anti-Cyclin E (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin D1 (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin A (1/200, Santa Cruz, Dallas, TX, USA), anti-β actin (1/50.000, Sigma, Saint Louis, MO, USA), anti-Glut4 (1/500, OSCRX), anti-TIMM50 (1/100, Abcam, Cambridge, UK), anti-Mtf2 (1/1000, Abcam, Cambridge, UK), anti-Drp1 (1/500, Abcam, Cambridge, UK), and anti-Na+/K+ ATPase (1/1000, Dev Studies Hybridoma Bank, University of Iowa, USA).

    Techniques: Incubation, Cell Cycle Assay

    Representative cartoon summarizing the participation of the mitochondrial Kv1.3 (mitoKv1.3) in the proliferation of preadipocytes. Kv1.3 would facilitate the G1/S transition of the cell cycle in preadipocytes accumulating at perinuclear mitochondria. The elucidation of a putative mitochondrial-nuclear communication during this phase of the cell cycle in which Kv1.3 would participate deserves much effort. During the G1/S transition, Kv1.3 would contribute to the mitochondrial fusion/fission equilibrium controlling the mitochondrial membrane potential. Ablation of Kv1.3 (Kv1.3KD) would impair mitochondrial dynamics during cell cycle progression. Kv1.3KD, 3T3-L1 preadipocytes, with a genetic ablation of Kv1.3. Green dots, Kv1.3 channels; magenta, mitochondrial network.

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Representative cartoon summarizing the participation of the mitochondrial Kv1.3 (mitoKv1.3) in the proliferation of preadipocytes. Kv1.3 would facilitate the G1/S transition of the cell cycle in preadipocytes accumulating at perinuclear mitochondria. The elucidation of a putative mitochondrial-nuclear communication during this phase of the cell cycle in which Kv1.3 would participate deserves much effort. During the G1/S transition, Kv1.3 would contribute to the mitochondrial fusion/fission equilibrium controlling the mitochondrial membrane potential. Ablation of Kv1.3 (Kv1.3KD) would impair mitochondrial dynamics during cell cycle progression. Kv1.3KD, 3T3-L1 preadipocytes, with a genetic ablation of Kv1.3. Green dots, Kv1.3 channels; magenta, mitochondrial network.

    Article Snippet: The membranes were immunoblotted with the following specific antibodies: anti-Kv1.3 (1/200, Neuromab, Davis, CA, USA), anti-Cyclin E (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin D1 (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin A (1/200, Santa Cruz, Dallas, TX, USA), anti-β actin (1/50.000, Sigma, Saint Louis, MO, USA), anti-Glut4 (1/500, OSCRX), anti-TIMM50 (1/100, Abcam, Cambridge, UK), anti-Mtf2 (1/1000, Abcam, Cambridge, UK), anti-Drp1 (1/500, Abcam, Cambridge, UK), and anti-Na+/K+ ATPase (1/1000, Dev Studies Hybridoma Bank, University of Iowa, USA).

    Techniques:

    Kv1.3 participates in the proliferation of preadipocytes. 3T3-L1 preadipocytes express Kv1.3, and genetic ablation of the channel alters cell proliferation. ( A ) Representative immunofluorescence confocal image of Kv1.3 in 3T3-L1 preadipocytes. The scale bar represents 20 µm. ( B ) Kv1.3 silencing in 3T3-L1 preadipocytes. Cells were infected with Kv1.3 shRNA (Kv1.3KD) or scramble shRNA (SCR) lentivirus. β-actin was used as a loading control. Noninfected 3T3-L1 cells were called wild-type (WT) cells. ( C ) Quantification of the efficiency of Kv1.3 silencing. The data are the mean ± SE ( n ≥ 3). * p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 participates in the proliferation of preadipocytes. 3T3-L1 preadipocytes express Kv1.3, and genetic ablation of the channel alters cell proliferation. ( A ) Representative immunofluorescence confocal image of Kv1.3 in 3T3-L1 preadipocytes. The scale bar represents 20 µm. ( B ) Kv1.3 silencing in 3T3-L1 preadipocytes. Cells were infected with Kv1.3 shRNA (Kv1.3KD) or scramble shRNA (SCR) lentivirus. β-actin was used as a loading control. Noninfected 3T3-L1 cells were called wild-type (WT) cells. ( C ) Quantification of the efficiency of Kv1.3 silencing. The data are the mean ± SE ( n ≥ 3). * p

    Article Snippet: The membranes were immunoblotted with the following specific antibodies: anti-Kv1.3 (1/200, Neuromab, Davis, CA, USA), anti-Cyclin E (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin D1 (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin A (1/200, Santa Cruz, Dallas, TX, USA), anti-β actin (1/50.000, Sigma, Saint Louis, MO, USA), anti-Glut4 (1/500, OSCRX), anti-TIMM50 (1/100, Abcam, Cambridge, UK), anti-Mtf2 (1/1000, Abcam, Cambridge, UK), anti-Drp1 (1/500, Abcam, Cambridge, UK), and anti-Na+/K+ ATPase (1/1000, Dev Studies Hybridoma Bank, University of Iowa, USA).

    Techniques: Immunofluorescence, Infection, shRNA

    Kv1.3 regulates the mitochondrial fusion/fission equilibrium during the G1/S transition. Confocal images showing mitochondria in cells fixed in the G0/G1 ( A – F ) and G1/S ( G – L ) phase for WT ( A – C , G – I ) and Kv1.3KD preadipocytes ( D – F , J – L ). The scale bar represents 20 µm. Images were processed (tubeness and skeleton) to perform morphometric analysis of mitochondria. ( M ) The length of mitochondrial networks was measured as the average area of the skeletonized binary image. ( N ) Number of mitochondrial particles per µm 2 . ( O ) The form factor describes the particle shape complexity and was computed as the average (perimeter)2/(4π·area). A circle corresponds to a minimum value of 1. The data are the mean ± SE ( n > 30). *, p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 regulates the mitochondrial fusion/fission equilibrium during the G1/S transition. Confocal images showing mitochondria in cells fixed in the G0/G1 ( A – F ) and G1/S ( G – L ) phase for WT ( A – C , G – I ) and Kv1.3KD preadipocytes ( D – F , J – L ). The scale bar represents 20 µm. Images were processed (tubeness and skeleton) to perform morphometric analysis of mitochondria. ( M ) The length of mitochondrial networks was measured as the average area of the skeletonized binary image. ( N ) Number of mitochondrial particles per µm 2 . ( O ) The form factor describes the particle shape complexity and was computed as the average (perimeter)2/(4π·area). A circle corresponds to a minimum value of 1. The data are the mean ± SE ( n > 30). *, p

    Article Snippet: The membranes were immunoblotted with the following specific antibodies: anti-Kv1.3 (1/200, Neuromab, Davis, CA, USA), anti-Cyclin E (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin D1 (1/200, Santa Cruz, Dallas, TX, USA), anti-Cyclin A (1/200, Santa Cruz, Dallas, TX, USA), anti-β actin (1/50.000, Sigma, Saint Louis, MO, USA), anti-Glut4 (1/500, OSCRX), anti-TIMM50 (1/100, Abcam, Cambridge, UK), anti-Mtf2 (1/1000, Abcam, Cambridge, UK), anti-Drp1 (1/500, Abcam, Cambridge, UK), and anti-Na+/K+ ATPase (1/1000, Dev Studies Hybridoma Bank, University of Iowa, USA).

    Techniques:

    Kv1.3 accumulates at perinuclear mitochondria during the G1/S transition. ( A ) Subcellular fractionation of 3T3-L1 wild-type preadipocytes to obtain the membranous (Mb) and mitochondrial (Mit) fractions. The samples were probed for Kv1.3, Na+/K+ ATPase (a membrane marker) and TIMM50 (a mitochondrial marker). ( B ) Electron micrograph showing mitochondria of 3T3-L1 wild-type preadipocytes. Kv1.3 was labeled with 18 nm immunogold particles (black arrowhead) and was located at the inner mitochondrial membrane. The scale bar represents 200 nm. ( C – H ) Cells were either in the G0/G1 or the G1/S phase following serum deprivation or serum readdition for 12 h, respectively. Representative confocal images showing Kv1.3 and mitochondria in wild-type preadipocytes fixed in the G0/G1 ( C – E ) and G1/S ( F – H ) phase. Ea-Eb and Ha-Hb are magnified images of E and H, respectively. Ea and Ha show distal regions, and Eb and Hb show perinuclear regions. Yellow indicates colocalization of Kv1.3 (green) and mitochondria (red). The scale bar represents 20 µm. ( I ) Pearson’s coefficient of colocalization between Kv1.3 and mitochondria. The data are the mean ± SE ( n > 30). *** p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 accumulates at perinuclear mitochondria during the G1/S transition. ( A ) Subcellular fractionation of 3T3-L1 wild-type preadipocytes to obtain the membranous (Mb) and mitochondrial (Mit) fractions. The samples were probed for Kv1.3, Na+/K+ ATPase (a membrane marker) and TIMM50 (a mitochondrial marker). ( B ) Electron micrograph showing mitochondria of 3T3-L1 wild-type preadipocytes. Kv1.3 was labeled with 18 nm immunogold particles (black arrowhead) and was located at the inner mitochondrial membrane. The scale bar represents 200 nm. ( C – H ) Cells were either in the G0/G1 or the G1/S phase following serum deprivation or serum readdition for 12 h, respectively. Representative confocal images showing Kv1.3 and mitochondria in wild-type preadipocytes fixed in the G0/G1 ( C – E ) and G1/S ( F – H ) phase. Ea-Eb and Ha-Hb are magnified images of E and H, respectively. Ea and Ha show distal regions, and Eb and Hb show perinuclear regions. Yellow indicates colocalization of Kv1.3 (green) and mitochondria (red). The scale bar represents 20 µm. ( I ) Pearson’s coefficient of colocalization between Kv1.3 and mitochondria. The data are the mean ± SE ( n > 30). *** p

    Article Snippet: The samples were mounted on Formvar-coated grids, and the sections were finally contrasted with uranyl acetate 2% for 15 min. Immunolabeling was performed with primary antibodies against Kv1.3 (1:5, Neuromab).

    Techniques: Fractionation, Marker, Labeling

    Kv1.3 regulates the mitochondrial membrane potential during the cell cycle. Ablation of Kv1.3 impairs the mitochondrial membrane potential. ( A ) TMRM intensity in wild-type (black bar) and Kv1.3KD (white bar) 3T3-L1 preadipocytes was analyzed with flow cytometry. The data are the mean ± SE ( n = 3), * p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 regulates the mitochondrial membrane potential during the cell cycle. Ablation of Kv1.3 impairs the mitochondrial membrane potential. ( A ) TMRM intensity in wild-type (black bar) and Kv1.3KD (white bar) 3T3-L1 preadipocytes was analyzed with flow cytometry. The data are the mean ± SE ( n = 3), * p

    Article Snippet: The samples were mounted on Formvar-coated grids, and the sections were finally contrasted with uranyl acetate 2% for 15 min. Immunolabeling was performed with primary antibodies against Kv1.3 (1:5, Neuromab).

    Techniques: Flow Cytometry

    Kv1.3 facilitates the G1/S transition of the cell cycle in preadipocytes. Serum-starved resting cells were incubated for the indicated time after serum readdition. ( A ) Cell cycle analysis of 3T3-L1 preadipocytes was performed with propidium iodide. Representative histograms at 0, 6, 12, 18 or 24 h after serum readdition. The cells exhibit two blue peaks corresponding to the G0/G1 (left) and G2 (right) phases. The cell population in purple corresponds to cells in the S phase. Left panels, wild-type preadipocytes; right panels, Kv1.3KD preadipocytes. ( B ) The % of cells in the G0/G1 phase, % of cells in the S phase and % of cells in the G2 phase for wild-type (black) and Kv1.3KD (white) preadipocytes. The data are the mean ± SE ( n = 4–10 independent experiments). Two-way ANOVA indicated p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 facilitates the G1/S transition of the cell cycle in preadipocytes. Serum-starved resting cells were incubated for the indicated time after serum readdition. ( A ) Cell cycle analysis of 3T3-L1 preadipocytes was performed with propidium iodide. Representative histograms at 0, 6, 12, 18 or 24 h after serum readdition. The cells exhibit two blue peaks corresponding to the G0/G1 (left) and G2 (right) phases. The cell population in purple corresponds to cells in the S phase. Left panels, wild-type preadipocytes; right panels, Kv1.3KD preadipocytes. ( B ) The % of cells in the G0/G1 phase, % of cells in the S phase and % of cells in the G2 phase for wild-type (black) and Kv1.3KD (white) preadipocytes. The data are the mean ± SE ( n = 4–10 independent experiments). Two-way ANOVA indicated p

    Article Snippet: The samples were mounted on Formvar-coated grids, and the sections were finally contrasted with uranyl acetate 2% for 15 min. Immunolabeling was performed with primary antibodies against Kv1.3 (1:5, Neuromab).

    Techniques: Incubation, Cell Cycle Assay

    Representative cartoon summarizing the participation of the mitochondrial Kv1.3 (mitoKv1.3) in the proliferation of preadipocytes. Kv1.3 would facilitate the G1/S transition of the cell cycle in preadipocytes accumulating at perinuclear mitochondria. The elucidation of a putative mitochondrial-nuclear communication during this phase of the cell cycle in which Kv1.3 would participate deserves much effort. During the G1/S transition, Kv1.3 would contribute to the mitochondrial fusion/fission equilibrium controlling the mitochondrial membrane potential. Ablation of Kv1.3 (Kv1.3KD) would impair mitochondrial dynamics during cell cycle progression. Kv1.3KD, 3T3-L1 preadipocytes, with a genetic ablation of Kv1.3. Green dots, Kv1.3 channels; magenta, mitochondrial network.

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Representative cartoon summarizing the participation of the mitochondrial Kv1.3 (mitoKv1.3) in the proliferation of preadipocytes. Kv1.3 would facilitate the G1/S transition of the cell cycle in preadipocytes accumulating at perinuclear mitochondria. The elucidation of a putative mitochondrial-nuclear communication during this phase of the cell cycle in which Kv1.3 would participate deserves much effort. During the G1/S transition, Kv1.3 would contribute to the mitochondrial fusion/fission equilibrium controlling the mitochondrial membrane potential. Ablation of Kv1.3 (Kv1.3KD) would impair mitochondrial dynamics during cell cycle progression. Kv1.3KD, 3T3-L1 preadipocytes, with a genetic ablation of Kv1.3. Green dots, Kv1.3 channels; magenta, mitochondrial network.

    Article Snippet: The samples were mounted on Formvar-coated grids, and the sections were finally contrasted with uranyl acetate 2% for 15 min. Immunolabeling was performed with primary antibodies against Kv1.3 (1:5, Neuromab).

    Techniques:

    Kv1.3 participates in the proliferation of preadipocytes. 3T3-L1 preadipocytes express Kv1.3, and genetic ablation of the channel alters cell proliferation. ( A ) Representative immunofluorescence confocal image of Kv1.3 in 3T3-L1 preadipocytes. The scale bar represents 20 µm. ( B ) Kv1.3 silencing in 3T3-L1 preadipocytes. Cells were infected with Kv1.3 shRNA (Kv1.3KD) or scramble shRNA (SCR) lentivirus. β-actin was used as a loading control. Noninfected 3T3-L1 cells were called wild-type (WT) cells. ( C ) Quantification of the efficiency of Kv1.3 silencing. The data are the mean ± SE ( n ≥ 3). * p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 participates in the proliferation of preadipocytes. 3T3-L1 preadipocytes express Kv1.3, and genetic ablation of the channel alters cell proliferation. ( A ) Representative immunofluorescence confocal image of Kv1.3 in 3T3-L1 preadipocytes. The scale bar represents 20 µm. ( B ) Kv1.3 silencing in 3T3-L1 preadipocytes. Cells were infected with Kv1.3 shRNA (Kv1.3KD) or scramble shRNA (SCR) lentivirus. β-actin was used as a loading control. Noninfected 3T3-L1 cells were called wild-type (WT) cells. ( C ) Quantification of the efficiency of Kv1.3 silencing. The data are the mean ± SE ( n ≥ 3). * p

    Article Snippet: The samples were mounted on Formvar-coated grids, and the sections were finally contrasted with uranyl acetate 2% for 15 min. Immunolabeling was performed with primary antibodies against Kv1.3 (1:5, Neuromab).

    Techniques: Immunofluorescence, Infection, shRNA

    Kv1.3 regulates the mitochondrial fusion/fission equilibrium during the G1/S transition. Confocal images showing mitochondria in cells fixed in the G0/G1 ( A – F ) and G1/S ( G – L ) phase for WT ( A – C , G – I ) and Kv1.3KD preadipocytes ( D – F , J – L ). The scale bar represents 20 µm. Images were processed (tubeness and skeleton) to perform morphometric analysis of mitochondria. ( M ) The length of mitochondrial networks was measured as the average area of the skeletonized binary image. ( N ) Number of mitochondrial particles per µm 2 . ( O ) The form factor describes the particle shape complexity and was computed as the average (perimeter)2/(4π·area). A circle corresponds to a minimum value of 1. The data are the mean ± SE ( n > 30). *, p

    Journal: Cancers

    Article Title: Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

    doi: 10.3390/cancers13174457

    Figure Lengend Snippet: Kv1.3 regulates the mitochondrial fusion/fission equilibrium during the G1/S transition. Confocal images showing mitochondria in cells fixed in the G0/G1 ( A – F ) and G1/S ( G – L ) phase for WT ( A – C , G – I ) and Kv1.3KD preadipocytes ( D – F , J – L ). The scale bar represents 20 µm. Images were processed (tubeness and skeleton) to perform morphometric analysis of mitochondria. ( M ) The length of mitochondrial networks was measured as the average area of the skeletonized binary image. ( N ) Number of mitochondrial particles per µm 2 . ( O ) The form factor describes the particle shape complexity and was computed as the average (perimeter)2/(4π·area). A circle corresponds to a minimum value of 1. The data are the mean ± SE ( n > 30). *, p

    Article Snippet: The samples were mounted on Formvar-coated grids, and the sections were finally contrasted with uranyl acetate 2% for 15 min. Immunolabeling was performed with primary antibodies against Kv1.3 (1:5, Neuromab).

    Techniques: